JP2008183239A - Device for confirming lumen passage - Google Patents

Device for confirming lumen passage Download PDF

Info

Publication number
JP2008183239A
JP2008183239A JP2007019911A JP2007019911A JP2008183239A JP 2008183239 A JP2008183239 A JP 2008183239A JP 2007019911 A JP2007019911 A JP 2007019911A JP 2007019911 A JP2007019911 A JP 2007019911A JP 2008183239 A JP2008183239 A JP 2008183239A
Authority
JP
Japan
Prior art keywords
dissolving
capsule
passage confirmation
lumen
lumen passage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007019911A
Other languages
Japanese (ja)
Other versions
JP4839236B2 (en
Inventor
Hironao Kono
宏尚 河野
Takeshi Yokoi
武司 横井
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Olympus Medical Systems Corp
Original Assignee
Olympus Medical Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olympus Medical Systems Corp filed Critical Olympus Medical Systems Corp
Priority to JP2007019911A priority Critical patent/JP4839236B2/en
Priority to EP08703541.6A priority patent/EP2106732B1/en
Priority to PCT/JP2008/050691 priority patent/WO2008093554A1/en
Priority to CN200880003574.7A priority patent/CN101600384B/en
Publication of JP2008183239A publication Critical patent/JP2008183239A/en
Priority to US12/512,386 priority patent/US20090292173A1/en
Application granted granted Critical
Publication of JP4839236B2 publication Critical patent/JP4839236B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

<P>PROBLEM TO BE SOLVED: To provide a device for confirming lumen passage capable of certainly keeping a capsular shape for a definite time necessary for confirming passing properties. <P>SOLUTION: The dissolving part 41 provided in the first non-dissolving part 42 for keeping a capsular shape is internally divided by a second non-dissolving part 63 to form the dissolving route 62 advancing into the dissolving part 41 from a part 43 of its surface. The dissolving time of the dissolving part 41 in a lumen is structurally made long by making the dissolving route 62 long to keep the capsular shape for a long time. <P>COPYRIGHT: (C)2008,JPO&INPIT

Description

本発明は、カプセル型内視鏡等のカプセル型医療装置を実際に使用する前に、被検者の体内に導入されて小腸等の管腔臓器内を通過し得るか否かを事前に確認するための管腔通過確認装置に関するものである。   Before actually using a capsule medical device such as a capsule endoscope, the present invention confirms in advance whether it can be introduced into the body of a subject and pass through a luminal organ such as the small intestine. The present invention relates to a lumen passage confirmation device.

近年、被検者の管腔臓器内を通過させて管腔内の観察、検査または処置などを行うカプセル型内視鏡などのカプセル型医療装置が提案され、実用化されている。このようなカプセル型医療装置を使用する上で、被検者の比較的狭い管腔臓器、例えば小腸等に狭窄部などの異常があると、飲み込まれたカプセル型医療装置が該狭窄部分で管腔内に滞留してしまうという問題がある。   2. Description of the Related Art In recent years, capsule medical devices such as capsule endoscopes that pass through a luminal organ of a subject and perform observation, examination, or treatment in the lumen have been proposed and put into practical use. When such a capsule medical device is used, if there is an abnormality such as a stenosis in a relatively narrow luminal organ of a subject, such as the small intestine, the swallowed capsule medical device is tubed at the stenosis. There is a problem of staying in the cavity.

このような問題に対して、実際のカプセル型医療装置と同等の大きさ、形状に形成されてカプセル型医療装置を使用する前に被検者の体内に導入させることで、事前に管腔内に狭窄部などのカプセル型医療装置が長時間滞留する可能性のある箇所の有無を確認する管腔通過確認用カプセル(内視鏡用プレテストカプセル)が提案されている(例えば、特許文献1〜4参照)。これにより、管腔通過確認用カプセルが正常に体外に排出されれば狭窄等の異常がなくカプセル型内視鏡の適用が可能と判断され、管腔通過確認用カプセルが正常に体外に排出されなれければ狭窄等の異常がありカプセル型内視鏡の適用が不適と判断される。この種の管腔通過確認用カプセルは、狭窄等による不通過を確認するために一定時間以上はカプセル形状の原形を維持し、一定時間経過後は狭窄部分等での体内滞留を避けるために溶解または分解して排出される必要性がある。このような要望に応えるため、管腔通過確認用カプセルの構成素材として、胃では溶解せず腸内で溶解する(酢酸/コハク酸)ヒドロキシプロピルメチルセルロース等のアルカリ可溶性の腸溶性材料を用いる等、材料に工夫を凝らしている。腸溶性材料としては、天然多糖類・多価アルコール組成物等も知られている(例えば、特許文献5,6参照)。   In order to deal with such a problem, it is formed in the same size and shape as an actual capsule medical device and introduced into the body of the subject before using the capsule medical device, so that There has been proposed a capsule for confirming passage of lumen (pretest capsule for endoscope) for confirming the presence or absence of a portion where a capsule-type medical device such as a stenosis may stay for a long time (for example, Patent Document 1). To 4). As a result, if the capsule for confirming passage of lumen is normally discharged from the body, it is determined that there is no abnormality such as stenosis and the capsule endoscope can be applied, and the capsule for checking passage of lumen is normally discharged from the body. If it is possible, there is an abnormality such as stenosis, and it is judged that application of the capsule endoscope is inappropriate. This type of capsule for confirming passage through the lumen maintains the original shape of the capsule for a certain period of time in order to confirm non-passage due to stenosis, etc., and dissolves in order to avoid retention in the stenotic part after a certain period of time. Or it needs to be disassembled and discharged. In order to respond to such a request, as a constituent material of the capsule for confirming passage through the lumen, an alkali-soluble enteric material such as hydroxypropylmethylcellulose (acetic acid / succinic acid) that does not dissolve in the stomach but dissolves in the intestine is used. The material is devised. As an enteric material, a natural polysaccharide / polyhydric alcohol composition and the like are also known (see, for example, Patent Documents 5 and 6).

特表2005−508668号公報JP 2005-508668 Gazette 特開2004−248956号公報JP 2004-248956 A 米国特許出願公開第2005/0063906号明細書US Patent Application Publication No. 2005/0063906 特開2006−142013号公報JP 2006-142013 A 特開平3−2328815号公報Japanese Patent Laid-Open No. 3-232815 特開平11−49668号公報JP 11-49668 A

しかしながら、特許文献1,2等によれば、管腔通過確認用カプセルの完全溶解時間(カプセル形状を維持できる時間)は、例えば100時間以上、或いは1日以上〜7日以内の如く設定することが望まれているものの、腸溶性材料に依存しているものであり、材料による溶解時間のコントロールは難しい。例示されるような腸溶性材料等の場合、管腔通過確認用カプセルの大きさからして溶解時間は1日程度が限界であり、所望通りの完全溶解時間を確保できない現状にある。管腔通過確認用カプセル等の体内通過時間は、正常者でも2〜3日はかかることは多々あり、被検者に依らず通過性を確認するために必要な一定時間を確保できず、通過性を確実に確認できないものである。   However, according to Patent Documents 1 and 2, etc., the complete dissolution time (time for maintaining the capsule shape) of the capsule for confirming passage of lumen is set to, for example, 100 hours or more, or from 1 day to 7 days. However, it depends on the enteric material, and it is difficult to control the dissolution time with the material. In the case of an enteric material as exemplified, the dissolution time is limited to about one day because of the size of the capsule for confirming passage through the lumen, and the desired complete dissolution time cannot be secured. The passage time in the body, such as capsules for confirming passage of lumens, often takes 2 to 3 days even for a normal person, and it is not possible to secure a certain amount of time necessary for confirming passage regardless of the subject. It is something that cannot be confirmed reliably.

本発明は、上記に鑑みてなされたものであって、通過性を確認するために必要な一定時間、カプセル形状を確実に維持させることができる管腔通過確認装置を提供することを目的とする。   The present invention has been made in view of the above, and an object of the present invention is to provide a lumen passage confirmation device that can reliably maintain the capsule shape for a certain period of time necessary for confirming passage. .

上述した課題を解決し、目的を達成するために、本発明に係る管腔通過確認装置は、体内に導入可能な大きさのカプセル形状を有する管腔通過確認装置であって、体内で溶解しない材料からなり、前記カプセル形状の表面の一部を除いて薄肉状に設けられた第1の非溶解部と、体内で溶解する材料からなり、外部に露出する前記カプセル形状の表面の一部を含み前記第1の非溶解部の内部に設けられた溶解部と、体内で溶解しない材料からなり、前記溶解部内を分割して該溶解部中に表面の前記一部から内部に進行する溶解経路を形成する第2の非溶解部と、を備えることを特徴とする。   In order to solve the above-described problems and achieve the object, a lumen passage confirmation device according to the present invention is a lumen passage confirmation device having a capsule shape that can be introduced into the body, and does not dissolve in the body. A first non-dissolved portion made of a material and excluding a part of the capsule-shaped surface, and a portion of the capsule-shaped surface exposed to the outside, made of a material that dissolves in the body. And a dissolution path that is made of a material that does not dissolve in the body and that divides the inside of the dissolution part and advances from the part of the surface into the dissolution part. And a second non-dissolving part that forms the structure.

また、本発明に係る管腔通過確認装置は、上記発明において、前記第2の非溶解部は、カプセル形状の中心方向に伸展するように設けられていることを特徴とする。   Moreover, the lumen passage confirmation device according to the present invention is characterized in that, in the above invention, the second non-dissolving part is provided so as to extend in the center direction of the capsule shape.

また、本発明に係る管腔通過確認装置は、上記発明において、体内で溶解しない材料からなり、前記溶解経路をさらに分割して細分化する第3の非溶解部を備えることを特徴とする。   In addition, the lumen passage confirmation device according to the present invention is characterized in that, in the above-mentioned invention, the lumen non-dissolving part is made of a material that does not dissolve in the body and further divides and subdivides the dissolution path.

また、本発明に係る管腔通過確認装置は、上記発明において、前記第2の非溶解部の端部は、カプセル形状の表面において第1の非溶解部の端部に繋がっていることを特徴とする。   Moreover, the lumen passage confirmation device according to the present invention is characterized in that, in the above invention, the end of the second non-dissolving portion is connected to the end of the first non-dissolving portion on the capsule-shaped surface. And

また、本発明に係る管腔通過確認装置は、上記発明において、前記第2の非溶解部は、前記第1の非溶解部に対して略平行で層状に設けられていることを特徴とする。   Moreover, the lumen passage confirmation device according to the present invention is characterized in that, in the above invention, the second non-dissolving part is provided in a layer form substantially parallel to the first non-dissolving part. .

また、本発明に係る管腔通過確認装置は、上記発明において、被認識部材を有することを特徴とする。   Moreover, the lumen passage confirmation device according to the present invention is characterized in that in the above invention, a recognized member is provided.

また、本発明に係る管腔通過確認装置は、上記発明において、前記被認識部材は、X線不透過材であることを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above invention, the member to be recognized is an X-ray opaque material.

また、本発明に係る管腔通過確認装置は、上記発明において、前記X線不透過材は、前記非溶解部に設けられていることを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above invention, the X-ray opaque material is provided in the non-dissolving portion.

また、本発明に係る管腔通過確認装置は、上記発明において、前記非溶解部は、金属膜からなることを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above invention, the non-dissolving part is made of a metal film.

また、本発明に係る管腔通過確認装置は、上記発明において、前記X線不透過材は、前記溶解部の少なくとも一部に内蔵されていることを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above-mentioned invention, the X-ray opaque material is built in at least a part of the dissolving portion.

また、本発明に係る管腔通過確認装置は、上記発明において、前記X線不透過材は、前記溶解経路の最奥部に配置されていることを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above invention, the X-ray impermeable material is disposed in the innermost part of the dissolution path.

また、本発明に係る管腔通過確認装置は、上記発明において、前記X線不透過材は、複数個所に離間配置されていることを特徴とする。   Moreover, the lumen passage confirmation device according to the present invention is characterized in that, in the above invention, the X-ray impermeable material is spaced apart at a plurality of locations.

また、本発明に係る管腔通過確認装置は、上記発明において、前記被認識部材は、前記溶解部に内蔵されたRF−IDタグであることを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above-mentioned invention, the member to be recognized is an RF-ID tag built in the dissolving portion.

また、本発明に係る管腔通過確認装置は、上記発明において、前記溶解部の少なくとも一部は、腸溶性材料からなることを特徴とする。   Moreover, the lumen passage confirmation device according to the present invention is characterized in that, in the above invention, at least a part of the dissolving portion is made of an enteric material.

また、本発明に係る管腔通過確認装置は、上記発明において、前記カプセル形状は、長手軸方向の両端に凸形状部を有するドーム型カプセル形状であることを特徴とする。   Moreover, the lumen passage confirmation device according to the present invention is characterized in that, in the above invention, the capsule shape is a dome-shaped capsule shape having convex portions at both ends in the longitudinal axis direction.

また、本発明に係る管腔通過確認装置は、上記発明において、前記カプセル形状は、球型カプセル形状であることを特徴とする。   The lumen passage confirmation device according to the present invention is characterized in that, in the above invention, the capsule shape is a spherical capsule shape.

また、本発明に係る管腔通過確認装置は、上記発明において、体内で溶解しない材料からなる前記非溶解部は、体内で溶解する時間が前記溶解部よりも長いことにより相対的に体内で溶解しない特性を示すことを特徴とする。   Further, the lumen passage confirmation device according to the present invention is the above invention, wherein the non-dissolved part made of a material that does not dissolve in the body dissolves relatively in the body because the dissolution time in the body is longer than the dissolution part. It is characterized by not exhibiting characteristics.

また、本発明に係る管腔通過確認装置は、上記発明において、前記溶解部は、X線不透過部材からなり、前記被認識部を兼ねることを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above invention, the dissolving portion is made of an X-ray opaque member and also serves as the recognized portion.

また、本発明に係る管腔通過確認装置は、上記発明において、前記被認識部は、バリウムまたは金属を含むことを特徴とする。   Moreover, the lumen passage confirmation apparatus according to the present invention is characterized in that, in the above invention, the recognized portion includes barium or metal.

本発明に係る管腔通過確認装置によれば、カプセル形状を維持する第1の非溶解部内に設けられた溶解部内を第2の非溶解部によって分割して溶解部中に表面の一部から内部に進行する溶解経路を形成しているので、溶解経路を長くすることで溶解部が管腔内で溶解する時間を構造的に長くすることができ、よって、カプセル形状を長時間維持することができ、通過性を確認するために必要な一定時間、カプセル形状を確実に維持することができ、管腔通過性を確実に確認することができるという効果を奏する。   According to the lumen passage confirmation device according to the present invention, the dissolving portion provided in the first non-dissolving portion that maintains the capsule shape is divided by the second non-dissolving portion so that a part of the surface enters the dissolving portion. Since the dissolution path that progresses inside is formed, the dissolution time can be structurally lengthened by lengthening the dissolution path, thereby maintaining the capsule shape for a long time. The capsule shape can be reliably maintained for a certain period of time necessary for confirming passage, and the lumen passage can be reliably confirmed.

また、本発明に係る管腔通過確認装置によれば、溶解経路を形成する第2の非溶解部がカプセル形状の中心方向に伸展するように設けられているので、カプセル形状の中心部分から外側に向けて溶解部を溶解させる溶解経路を形成することができ、カプセル形状の外表面をなす第1の非溶解部近傍の溶解部が溶解するまでの時間を長くすることができ、よって、長時間カプセル形状を維持することができるという効果を奏する。   Further, according to the lumen passage confirmation device according to the present invention, since the second non-dissolving part forming the dissolution path is provided so as to extend in the center direction of the capsule shape, the capsule-shaped center portion is outside. The dissolution path for dissolving the dissolution portion toward the surface can be formed, and the time until the dissolution portion in the vicinity of the first non-dissolution portion that forms the outer surface of the capsule shape can be increased. There is an effect that the time capsule shape can be maintained.

また、本発明に係る管腔通過確認装置によれば、溶解経路を第3の非溶解部によってさらに分割して細分化しているので、溶解経路をさらに長くして、より一層長時間カプセル形状を維持することができるという効果を奏する。   Further, according to the lumen passage confirmation device according to the present invention, the dissolution path is further divided and subdivided by the third non-dissolution part, so that the dissolution path is further lengthened and the capsule shape is further increased for a longer time. There is an effect that it can be maintained.

また、本発明に係る管腔通過確認装置によれば、第2の非溶解部の端部が第1の非溶解部の端部に繋がっているので、カプセル形状外表面において第1の非溶解部と第2の非溶解部との連続性を確保でき、よって、第1の非溶解部の端部からカプセル形状が崩壊するようなことがなく、長時間カプセル形状を維持することができるという効果を奏する。   Further, according to the lumen passage confirmation device according to the present invention, since the end of the second non-dissolving part is connected to the end of the first non-dissolving part, the first non-dissolving is performed on the capsule-shaped outer surface. The continuity between the part and the second non-dissolving part can be ensured, so that the capsule shape does not collapse from the end of the first non-dissolving part, and the capsule shape can be maintained for a long time. There is an effect.

また、本発明に係る管腔通過確認装置によれば、第2の非溶解部が第1の非溶解部に対して略平行で層状に設けられているので、溶解経路をカプセル形状の周方向に大面積化して形成することができ、よって、溶解経路の溶解部が溶解するまでの時間を長くすることができ、長時間カプセル形状を維持することができるという効果を奏する。   Further, according to the lumen passage confirmation device according to the present invention, since the second non-dissolving portion is provided in layers in parallel with the first non-dissolving portion, the dissolution path is arranged in the capsule-shaped circumferential direction. Therefore, it is possible to increase the time until the dissolution part of the dissolution path is dissolved, and to maintain the capsule shape for a long time.

以下、添付図面を参照して、本発明に係る管腔通過確認装置の好適な実施の形態である管腔通過確認カプセルについて説明する。各実施の形態や各変形例における管腔通過確認カプセルは、通過性を確認する管腔として、例えば胃腸を適用対象とする例で説明する。なお、各実施の形態により本発明が限定されるものではない。また、図面の記載において、同一部分又は相当する部分には同一の符号を付している。   Hereinafter, a lumen passage confirmation capsule which is a preferred embodiment of a lumen passage confirmation device according to the present invention will be described with reference to the accompanying drawings. The lumen passage confirmation capsule in each embodiment and each modification will be described with an example in which, for example, the gastrointestinal tract is applied as a lumen for confirming passage. In addition, this invention is not limited by each embodiment. In the description of the drawings, the same or corresponding parts are denoted by the same reference numerals.

(実施の形態1)
本発明の実施の形態1に係る管腔通過確認カプセルについて図1および図2を参照して説明する。図1は、本実施の形態1に係る管腔通過確認カプセル10の構成例を示す概略斜視図であり、図2は、その中央縦断側面図である。
(Embodiment 1)
A lumen passage confirmation capsule according to Embodiment 1 of the present invention will be described with reference to FIG. 1 and FIG. FIG. 1 is a schematic perspective view showing a configuration example of a lumen passage confirmation capsule 10 according to the first embodiment, and FIG. 2 is a central longitudinal side view thereof.

本実施の形態1に係る管腔通過確認カプセル10は、概略的には、胃腸等の管腔内検査・観察を目的としたカプセル型内視鏡と同じまたはほぼ同等の形状、大きさで被検者の体内に導入可能なものであって、長手軸方向の両端に半球ドーム形状の凸形状部11a,11bを有するドーム型カプセル形状からなる。このようなドーム型カプセル形状の管腔通過確認カプセル10は、非溶解部12と、溶解部13と、第2の溶解部14と、被認識部15とにより構成されている。   The lumen passage confirmation capsule 10 according to the first embodiment is generally covered with a shape and size that is the same as or substantially the same as a capsule endoscope for the purpose of intraluminal inspection / observation such as gastrointestinal tract. It can be introduced into the examiner's body and has a dome-shaped capsule shape having hemispherical dome-shaped convex portions 11a and 11b at both ends in the longitudinal axis direction. Such a dome-shaped capsule-shaped lumen passage confirmation capsule 10 includes a non-dissolving part 12, a dissolving part 13, a second dissolving part 14, and a recognized part 15.

非溶解部12は、基本的に体内で溶解しない実質的に体液などに対して非浸透性(不透過性)である材料、例えば軟性を有する金属や樹脂などからなり、一部を除いてドーム型カプセル形状の表層をなしドーム型カプセル形状の外形形状を形成する構造体をなす薄肉部である。溶解部13は、体内で溶解する材料からなり、溶解することで非溶解部12が小さくなる方向に変形するようにドーム型カプセル形状の表層に線状に形成された一部に設けられている。すなわち、非溶解部12の一部に剛性を維持できないように線状の欠け部分を形成し、該欠け部分に溶解部13を充填することで剛性を確保してドーム型カプセル形状を維持する表層が形成されている。本実施の形態1では、溶解部13は、少なくともドーム型カプセル形状の長手軸方向の両端の凸形状部11a,11b間に亘ってドーム型カプセル形状の長手軸方向に直線的に線状に設けられている。なお、溶解部13は、非溶解部12の欠け部分だけでなく、欠け部分近傍の内壁面側部分に対しても多少入り込むように設けられ、溶解部13の溶解に一定時間以上(例えば、1〜2日以上)要するように設定されている。   The non-dissolving part 12 is basically made of a material that does not dissolve in the body and is substantially impermeable (impermeable) to body fluids, such as a soft metal or resin. This is a thin-walled portion forming a structure that forms the outer shape of the dome-shaped capsule shape and forms a surface layer of the capsular shape. The dissolving portion 13 is made of a material that dissolves in the body, and is provided on a part of the dome-shaped capsule-shaped surface layer that is linearly formed so as to be deformed in a direction in which the non-dissolving portion 12 becomes smaller when dissolved. . That is, a surface layer in which a linear chipped portion is formed in a part of the non-dissolved portion 12 so that the rigidity cannot be maintained, and the melted portion 13 is filled in the chipped portion to ensure rigidity and maintain a dome-shaped capsule shape. Is formed. In the first embodiment, the dissolving portion 13 is linearly provided linearly in the longitudinal direction of the dome-shaped capsule shape across at least the convex-shaped portions 11a and 11b at both ends in the longitudinal direction of the dome-shaped capsule shape. It has been. The dissolving portion 13 is provided so as to enter not only the notch portion of the non-dissolving portion 12 but also the inner wall surface portion in the vicinity of the notch portion. ~ 2 days or more).

第2の溶解部14は、管腔内において溶解部13が溶解した後に溶解するように、表層を形成する非溶解部12の内部に設けられて管腔通過確認カプセル10の内容物をなすものである。ここで、第2の溶解部14は、溶解部13の溶解性よりも高い溶解性を有する材料により構成されている。本実施の形態1では、溶解部13は、胃では溶解しにくく、小腸から大腸を通過する過程で溶解する腸溶性材料、例えば、特許文献3中に示されるような(酢酸/コハク酸)ヒドロキシプロピルメチルセルロース等のアルカリ可溶性材料や、特許文献4,5等に示されるような多価アルコール、糖アルコール、単糖類、二糖類、三糖類およびオリゴ糖から選ばれた少なくとも一種の系の中で、カラギーナン、アルギン酸、アルギン酸塩、アルギン酸誘導体、寒天、ローカストビーンガム、グアーガム、アミロペクチン、ペクチン、キサンタンガム、グルコマンナン、キチン質およびプルランから選ばれた少なくとも一種の天然多糖類を均一に混錬して得られた天然多糖類・多価アルコール組成物で形成されている。一方、第2の溶解部14は、溶解しやすい溶解材料、例えば、天然高分子のキトサン、ゼラチン、セルロース等を主成分とする材料により形成されている。   The second dissolving part 14 is provided inside the non-dissolving part 12 forming the surface layer so as to dissolve after the dissolving part 13 is dissolved in the lumen, and constitutes the contents of the lumen passage confirmation capsule 10 It is. Here, the second dissolving portion 14 is made of a material having a solubility higher than that of the dissolving portion 13. In the first embodiment, the dissolving portion 13 is an enteric material that is difficult to dissolve in the stomach and dissolves in the process of passing from the small intestine to the large intestine, for example, (acetic acid / succinic acid) hydroxy as shown in Patent Document 3. Among at least one system selected from alkali-soluble materials such as propylmethylcellulose, polyhydric alcohols, sugar alcohols, monosaccharides, disaccharides, trisaccharides and oligosaccharides as shown in Patent Documents 4 and 5 Obtained by uniformly kneading at least one natural polysaccharide selected from carrageenan, alginic acid, alginates, alginic acid derivatives, agar, locust bean gum, guar gum, amylopectin, pectin, xanthan gum, glucomannan, chitin and pullulan Natural polysaccharide / polyhydric alcohol composition. On the other hand, the second dissolving portion 14 is formed of a dissolving material that is easy to dissolve, for example, a material mainly composed of natural polymers such as chitosan, gelatin, and cellulose.

被認識部15は、被検者の体外から認識装置によってその存在を認識することで、管腔通過確認カプセル10等の体内滞留位置、現在通過位置等を確認するためのものであり、X線不透過部材、例えば硫酸バリウム、金属(金、チタン、ステンレス等)や、電子的IDタグ、例えばRF−ID(Radio Frequency Identification))タグなどである。被認識部15が、硫酸バリウム、金属のようなX線不透過部材の場合、X線透視装置で被検者の体内を透視してX線不透過部材の存在の有無を確認することで、管腔通過確認カプセル10の狭窄部等での滞留の有無を確認できる。一方、被認識部15が、RF−IDタグのような電子的IDタグの場合、タグ用のリーダ・ライタを用いて電子的タグに電力を送信してICチップを動作させ、タグから必要な情報を受け取ることでタグの存在を認識できる。被認識部15は、単体では狭窄部等であっても通過し得る程度の大きさのものが用いられ、第2の溶解部14中であって管腔通過確認カプセル10の中央部に配置されているが、配置箇所は特に中央部に限られない。また、表層の非溶解部12が金属製の場合、この非溶解部12自身を被認識部15として用いることで、第2の溶解部14中に設けなくてもよい。   The recognition unit 15 is for confirming the presence in the body such as the lumen passage confirmation capsule 10 and the current passage position by recognizing its presence from the outside of the subject's body by the recognition device. An impermeable member such as barium sulfate, metal (gold, titanium, stainless steel, etc.), an electronic ID tag, such as an RF-ID (Radio Frequency Identification) tag, or the like. When the recognition unit 15 is an X-ray opaque member such as barium sulfate or metal, the presence of the X-ray opaque member is confirmed by seeing through the body of the subject with an X-ray fluoroscope. It is possible to confirm whether or not the lumen passage confirmation capsule 10 stays in the stenosis portion or the like. On the other hand, when the recognized portion 15 is an electronic ID tag such as an RF-ID tag, power is transmitted to the electronic tag using a reader / writer for the tag to operate the IC chip, and the necessary tag is used. The presence of the tag can be recognized by receiving the information. The recognized part 15 is a single part having a size that can pass even if it is a stenosis part or the like, and is arranged in the center of the lumen passage confirmation capsule 10 in the second dissolving part 14. However, the arrangement location is not particularly limited to the central portion. Further, when the non-dissolving portion 12 on the surface layer is made of metal, the non-dissolving portion 12 itself may be used as the recognized portion 15 so that it does not have to be provided in the second dissolving portion 14.

このような管腔通過確認カプセル10は、例えばドーム型カプセル形状の一部に欠け部分が形成された非溶解部12内に被認識部15を含めて第2の溶解部14を充填し、欠け部分に沿って溶解部13を充填することで形成される。   Such a lumen passage confirmation capsule 10 is filled with the second dissolving portion 14 including the recognized portion 15 in the non-dissolving portion 12 in which the notched portion is formed in a part of the dome-shaped capsule shape, for example. It is formed by filling the melting part 13 along the part.

このように構成された管腔通過確認カプセル10は、適用対象となるカプセル型内視鏡による管腔内検査・観察に先立ち、所定時間前(例えば、数日前)に、被検者が口腔より体内に導入することで、小腸等の管腔臓器内を通過し得るか否かが事前に確認される。   The luminal passage confirmation capsule 10 configured in this way is used by the subject from the oral cavity a predetermined time (for example, several days ago) prior to the intraluminal examination / observation by the capsule endoscope to be applied. Whether it can pass through a hollow organ such as the small intestine by being introduced into the body is confirmed in advance.

ここで、体内に導入された管腔通過確認カプセル10は、本来のカプセル型内視鏡と同様の大きさ、形状に形成されており、管腔内に狭窄部等により極端に狭くなった異常な部分がなければ、管腔の蠕動運動等に従い、胃、小腸、大腸等の管腔を順次通過して最終的には体外に排出されることとなる。この際、管腔通過確認カプセル10の表層は、その大半が非溶解部12として形成されているとともに、表層の一部として外部に露出している線状の溶解部13は腸溶性材料により形成されているので、管腔通過確認カプセル10は、胃を通過するまでは胃液等の体液によって溶解することなく進行する。そして、小腸〜大腸内を通過する過程で、管腔通過確認カプセル10は、腸溶性材料からなる溶解部13が徐々に溶解しながら進行することとなるが、溶解部13が溶解するまでの一定時間内の間は、ドーム型カプセル形状が維持される。従って、小腸等に狭窄部等の異常がなければ、管腔通過確認カプセル10はドーム型カプセル形状を維持したまま小腸〜大腸内で滞留することなく進行し、一定時間内に体外に排出されることで、管腔に狭窄部等の異常がないこと、すなわち、本来のカプセル型内視鏡が支障なく通過し得ることが確認される。   Here, the lumen passage confirmation capsule 10 introduced into the body is formed in the same size and shape as the original capsule endoscope, and is abnormally narrowed due to a stenosis or the like in the lumen. If there is no such part, according to the peristaltic movement of the lumen, etc., it sequentially passes through the lumen of the stomach, small intestine, large intestine, etc., and is finally discharged out of the body. At this time, most of the surface layer of the lumen passage confirmation capsule 10 is formed as the non-dissolved portion 12, and the linear dissolved portion 13 exposed to the outside as a part of the surface layer is formed of an enteric material. Therefore, the lumen passage confirmation capsule 10 proceeds without being dissolved by body fluid such as gastric fluid until it passes through the stomach. In the process of passing through the small intestine to the large intestine, the lumen passage confirmation capsule 10 proceeds while the dissolution part 13 made of the enteric material is gradually dissolved, but it remains constant until the dissolution part 13 dissolves. During the time, the dome-shaped capsule shape is maintained. Accordingly, if there is no abnormality such as a stenosis in the small intestine or the like, the lumen passage confirmation capsule 10 proceeds without staying in the small intestine to the large intestine while maintaining the dome-shaped capsule shape, and is discharged outside the body within a predetermined time. Thus, it is confirmed that there is no abnormality such as a stenosis in the lumen, that is, the original capsule endoscope can pass without any trouble.

一方、小腸等の部位において、狭窄部等の異常があると、蠕動運動を受けても管腔通過確認カプセル10の進行が阻害されて狭窄部等で滞留する。そして、滞留時間の経過とともに、線状の溶解部13の溶解が進行し、一定時間が経過すると全ての溶解部13が溶解し、遂には第2の溶解部14が外部に露出して溶解を開始するに至る。この際、第2の溶解部14は、溶解部13よりも溶解性の高い材料からなるので、第2の溶解部14は短時間で溶解して溶解部13のなくなった非溶解部12の欠け部分から小腸内に流出し、非溶解部12内は短時間で空洞化する。このように空洞化した管腔通過確認カプセル10において残存する非溶解部12は、線状に形成された欠け部分の溶解部13がなくなることでドーム型カプセル形状を維持するための剛性が低下し小さくなる方向に変形しやくなっており、小腸の蠕動運動を受けることで、外径が小さくなるように潰される。これにより、一定時間内に小腸内を通過できず狭窄部等で滞留した場合でも、一定時間後には潰れて小さくなることで狭窄部等を確実に通過させ排出させることが可能となり、管腔内に滞留したままとなることはない。特に、本実施の形態1では、溶解部13がドーム型カプセル形状の長手軸方向の両端間に亘って長手軸方向に線状に形成されているので、溶解部13が溶解することでドーム型カプセル形状をなす非溶解部12を径方向に潰れやすくして進行方向の径を小さくすることができ、狭窄部等での通過性を高めることができる。   On the other hand, if there is an abnormality such as a stenosis in a region such as the small intestine, the progression of the lumen passage confirmation capsule 10 is inhibited and stays in the stenosis or the like even when subjected to peristalsis. Then, as the residence time elapses, the dissolution of the linear dissolution part 13 proceeds, and when a certain time elapses, all the dissolution parts 13 are dissolved, and finally the second dissolution part 14 is exposed to the outside and dissolved. To get started. At this time, since the second dissolving portion 14 is made of a material having higher solubility than the dissolving portion 13, the second dissolving portion 14 is dissolved in a short time and the missing portion of the non-dissolving portion 12 where the dissolving portion 13 disappears. It flows out from the portion into the small intestine, and the inside of the non-dissolving portion 12 is hollowed out in a short time. The non-dissolving part 12 remaining in the hollow passage confirmation capsule 10 thus hollowed out loses the rigidity for maintaining the dome-shaped capsule shape by eliminating the dissolving part 13 of the chipped part formed in a linear shape. It is easy to deform in the direction of decreasing, and it is crushed so that the outer diameter decreases by receiving the peristaltic motion of the small intestine. As a result, even if it cannot pass through the small intestine within a certain period of time and stays in the stenosis, etc., it can be crushed and reduced after a certain period of time so that the stenosis can be reliably passed through and discharged. Will not stay in the water. In particular, in the first embodiment, the melting portion 13 is formed linearly in the longitudinal axis direction across the both ends of the dome-shaped capsule shape in the longitudinal axis direction. The non-dissolving portion 12 having a capsule shape can be easily crushed in the radial direction, the diameter in the traveling direction can be reduced, and the passage through the constricted portion can be enhanced.

また、一定時間以上経過後においては、被検者の体外から認識装置によって被認識部15の存在の有無を認識することで、一定時間以上経過後も管腔通過確認カプセル10が管腔内に滞留しているか否かを再確認することもできる。   Further, after a predetermined time or more has elapsed, the presence / absence of the recognition unit 15 is recognized by the recognition device from outside the subject's body, so that the lumen passage confirmation capsule 10 remains in the lumen even after a certain time or more has elapsed. It can be reconfirmed whether or not it is staying.

(変形例1)
図3は、変形例1の管腔通過確認カプセル10Aを示す概略縦断側面図である。変形例1の管腔通過確認カプセル10Aは、ドーム型カプセル形状の表層を形成する非溶解部12に弾性を持たせたものである。この際、図3(a)に示すように、非溶解部12の欠け部分の端部同士は、重なり合わないように半径方向に段違い状態とされて、溶解部13が充填されている。図2の場合に準じて図3(a)のように形成された変形例1の管腔通過確認カプセル10Aによれば、小腸内において滞留し、線状の溶解部13が溶解して内部の第2の溶解部14が溶解しながら外部に流出して空洞化すると、溶解部13の存在によりドーム型カプセル形状を維持していた管腔通過確認カプセル10Aは、図3(b)に示すように非溶解部12の弾性によって強制的に径が小さくなる方向に丸まるように変形し、滞留部を通過しやすくなる。
(Modification 1)
FIG. 3 is a schematic longitudinal side view showing the lumen passage confirmation capsule 10A of the first modification. The lumen passage confirmation capsule 10A of the first modification is obtained by giving elasticity to the non-dissolving portion 12 that forms the surface layer of the dome-shaped capsule shape. At this time, as shown in FIG. 3A, the end portions of the chipped portions of the non-dissolved portion 12 are stepped in the radial direction so as not to overlap each other, and the melted portion 13 is filled. According to the lumen passage confirmation capsule 10A of the modified example 1 formed as shown in FIG. 3 (a) according to the case of FIG. 2, it stays in the small intestine, and the linear dissolution part 13 dissolves to dissolve the inside. When the second dissolution part 14 flows out to the outside while being melted to form a cavity, the lumen passage confirmation capsule 10A maintaining the dome-shaped capsule shape due to the presence of the dissolution part 13 is as shown in FIG. The non-dissolved portion 12 is deformed so as to be rounded in a direction in which the diameter is forcibly reduced due to the elasticity of the non-dissolved portion 12, and easily passes through the staying portion.

(変形例2)
図4は、変形例2の管腔通過確認カプセル10Bを示す概略斜視図である。変形例2の管腔通過確認カプセル10Bは、非溶解部12に対する溶解部13を、ドーム型カプセル形状の長手軸周りの周方向に螺旋状なる線状に設けたものである。変形例2の管腔通過確認カプセル10Bによれば、小腸内において滞留し、螺旋状の溶解部13が溶解して内部の第2の溶解部14が溶解しながら外部に流出して空洞化すると、溶解部13の存在によりドーム型カプセル形状を維持していた管腔通過確認カプセル10Bの非溶解部12は、剛性が低下してドーム型カプセル形状を維持し得ず軸方向にばらけるように潰れ、滞留部を通過しやすくなる。なお、螺旋状をなす条数は、適宜設定すればよい。また、螺旋状の端部は、極力凸形状部11a,11bの端部まで形成することが好ましい。
(Modification 2)
FIG. 4 is a schematic perspective view showing a lumen passage confirmation capsule 10B of the second modification. In the lumen passage confirmation capsule 10B of the second modification, the dissolving portion 13 for the non-dissolving portion 12 is provided in a spiral shape in the circumferential direction around the longitudinal axis of the dome-shaped capsule shape. According to the lumen passage confirmation capsule 10B of the modified example 2, when the capsule stays in the small intestine, the spiral dissolving portion 13 dissolves and the inner second dissolving portion 14 dissolves and flows out to the outside and becomes hollow. The non-dissolving portion 12 of the lumen passage confirmation capsule 10B that has maintained the dome-shaped capsule shape due to the presence of the dissolving portion 13 is so stiff that the dome-shaped capsule shape cannot be maintained due to a decrease in rigidity. It is easy to be crushed and pass through the staying part. In addition, what is necessary is just to set the number of strips which make a spiral shape suitably. Further, it is preferable that the spiral end portion is formed up to the end portions of the convex shape portions 11a and 11b as much as possible.

(変形例3)
図5は、変形例3の管腔通過確認カプセル10Cを示す概略斜視図であり、図6はその端面側面図である。変形例2の管腔通過確認カプセル10Cは、非溶解部12に対する溶解部13を、ドーム型カプセル形状の両端の凸形状部11a,11bにおいてX字状に交差する線状に設けたものである。変形例3の管腔通過確認カプセル10Cによれば、小腸内において滞留し、螺旋状の溶解部13が溶解して内部の第2の溶解部14が溶解しながら外部に流出して空洞化すると、溶解部13の存在によりドーム型カプセル形状を維持していた管腔通過確認カプセル10Cの非溶解部12は、剛性が高い両端の凸形状部11a,11bの剛性が低下してドーム型カプセル形状を維持し得ず、全体として円筒形状に空洞化されて潰れやすくなり、滞留部を通過しやすくなる。なお、凸形状部11a,11bで交差させる線は2本に限らず、さらに本数を増やして一層潰れやすくしてもよい。また、凸形状部11a,11bに形成された線状の溶解部13は、長手軸方向の中心寄り位置まで伸ばすように形成し、一層潰れやすくしてもよい。
(Modification 3)
FIG. 5 is a schematic perspective view showing a lumen passage confirmation capsule 10C of Modification 3, and FIG. 6 is an end side view thereof. The lumen passage confirmation capsule 10C of Modification 2 is provided with the dissolving portion 13 for the non-dissolving portion 12 in a line shape that intersects in an X shape at the convex shape portions 11a and 11b at both ends of the dome-shaped capsule shape. . According to the lumen passage confirmation capsule 10C of the third modification, the capsule stays in the small intestine, and when the spiral dissolving portion 13 dissolves and the second second dissolving portion 14 dissolves and flows out to the outside, it becomes hollow. In the non-dissolving portion 12 of the lumen passage confirmation capsule 10C that has maintained the dome-shaped capsule shape due to the presence of the dissolving portion 13, the rigidity of the convex-shaped portions 11a and 11b at both ends with high rigidity decreases, and the dome-shaped capsule shape Cannot be maintained, and is hollowed into a cylindrical shape as a whole and easily crushed, and easily passes through the staying portion. Note that the number of lines intersecting at the convex portions 11a and 11b is not limited to two, and the number of lines may be further increased to make it easier to collapse. Moreover, the linear melt | dissolution part 13 formed in the convex-shaped parts 11a and 11b may be formed so that it may extend to the position near the center of a longitudinal axis direction, and may be crushed more easily.

(実施の形態2)
本発明の実施の形態2に係る管腔通過確認カプセルについて図7および図8を参照して説明する。図7は、本実施の形態2に係る管腔通過確認カプセル20の構成例を示す概略斜視図であり、図8は、その中央縦断側面図である。
(Embodiment 2)
A lumen passage confirmation capsule according to Embodiment 2 of the present invention will be described with reference to FIGS. FIG. 7 is a schematic perspective view showing a configuration example of the lumen passage confirmation capsule 20 according to the second embodiment, and FIG. 8 is a central longitudinal side view thereof.

本実施の形態2の管腔通過確認カプセル20は、基本的には実施の形態1の管腔通過確認カプセル10に準じて構成されているが、非溶解部12に対して線状に形成される2本の溶解部13をその線の方向に周回させて非溶解部12を分断させることで、非溶解部12が線状の溶解部13によって連結される複数、例えば4つのシート状部材12aからなるように構成したものである。すなわち、溶解部13は、実施の形態1と変形例3の組合せからなり、長手軸方向に線状に形成された部分と凸形状部11a,11bに線状に形成された部分とが長手軸方向に連続して非溶解部12を分断し、溶解部13の存在によりドーム型カプセル形状を維持し得る構造とされている。   The lumen passage confirmation capsule 20 according to the second embodiment is basically configured according to the lumen passage confirmation capsule 10 according to the first embodiment, but is formed linearly with respect to the non-dissolving portion 12. By rotating the two melting portions 13 in the direction of the line and dividing the non-dissolving portion 12, a plurality of, for example, four sheet-like members 12 a connected to the non-dissolving portion 12 by the linear melting portion 13. It is comprised so that it may consist of. That is, the melting part 13 is a combination of the first embodiment and the third modification, and the part formed linearly in the longitudinal axis direction and the part formed linearly in the convex parts 11a, 11b are longitudinal axes. The non-dissolving part 12 is divided continuously in the direction, and the dome-shaped capsule shape can be maintained by the presence of the dissolving part 13.

本実施の形態2の管腔通過確認カプセル20によれば、小腸内において滞留し、線状の溶解部13が溶解すると、溶解部13の存在によりドーム型カプセル形状を維持していた管腔通過確認カプセル20の非溶解部12は、ドーム型カプセル形状を維持できず、それぞれシート状部材12aに確実に分断されて小さくなる方向に変形し、狭窄部等を通過しやすくなる。なお、溶解部13の本数は2本に限らず、さらに本数を増やすことで分断される非溶解部12のシート状部材の個数を増やして個々が小さくなるようにしてもよい。   According to the lumen passage confirmation capsule 20 of the second embodiment, when the linear dissolution portion 13 is retained in the small intestine and dissolved, the passage through the lumen that has maintained the dome-shaped capsule shape due to the presence of the dissolution portion 13 is achieved. The non-dissolving portion 12 of the confirmation capsule 20 cannot maintain the dome-shaped capsule shape, and is surely divided by the sheet-like member 12a and deformed in a smaller direction, and easily passes through the constricted portion or the like. In addition, the number of the melt | dissolution parts 13 is not restricted to two, You may make it increase by increasing the number of the sheet-like members of the non-dissolution part 12 divided | segmented by increasing the number, and each may become small.

(変形例4)
図9は、変形例4の管腔通過確認カプセル20Aを示す概略斜視図である。変形例4の管腔通過確認カプセル20Aは、非溶解部12に対する溶解部13を、長手軸方向に周回する線状だけでなく、長手軸周りの周方向に周回する線状にも設けることで、非溶解部12をさらに細分化された複数のシート状部材12bに分断させたものである。変形例4の管腔通過確認カプセル20Aによれば、溶解部13が溶解した場合に、非溶解部12をシート状部材12bに細分化させて小さくすることができ、滞留部を一層通過しやすくなる。この場合の溶解部13の本数も適宜設定すればよく、また、長手軸方向、周方向のいずれについても斜め方向であってもよく、螺旋状との組合せであってもよい。
(Modification 4)
FIG. 9 is a schematic perspective view showing the lumen passage confirmation capsule 20A of the fourth modification. The lumen passage confirmation capsule 20A according to the modified example 4 is provided not only with a linear shape that circulates in the longitudinal axis direction but also with a linear shape that circulates in the circumferential direction around the longitudinal axis. The non-dissolving part 12 is divided into a plurality of further divided sheet-like members 12b. According to the lumen passage confirmation capsule 20A of the modified example 4, when the dissolving portion 13 is dissolved, the non-dissolving portion 12 can be subdivided into the sheet-like member 12b and can be made smaller, making it easier to pass through the staying portion. Become. In this case, the number of the melting portions 13 may be set as appropriate, and both the longitudinal axis direction and the circumferential direction may be oblique directions, or a combination with a spiral shape.

(変形例5)
図10は、変形例5の管腔通過確認カプセル20Bを示す中央縦断側面図であり、図11は、分断された非溶解部の変形の様子を示す断面図である。変形例5の管腔通過確認カプセル20Bは、図10(a)に示すように、非溶解部12の内側にも溶解部13を介して体内で溶解しない材料からなる第2の非溶解部16を略平行に層状に設けることで、非溶解部を2層構造とするとともに、第2の非溶解部16の一部にも図7に示した場合と同様に第2の非溶解部16を長手軸方向に沿って線状に分断して複数のシート状部材16aに細分化する欠け部分を形成しこの欠け部分に溶解部13を充填して連結させたものである。これにより、第2の非溶解部16は、溶解部(溶解部13と第2の溶解部14)内を分割してこれら溶解部13,14中に表面の一部(欠け部分)から内部に進行する溶解経路17を周方向に沿って断続的な断面円弧状に形成している。ここで、非溶解部12の溶解部13による分断位置(欠け部分)と第2の非溶解部16の溶解部13による分断位置(欠け部分)とは、カプセル型カプセル形状の長手軸周りの周方向においてずれている。変形例5では、等間隔にずれており、溶解経路17が等分に極力長くなるように設定されている。また、非溶解部12,16を構成するシート状部材12a,16aは、弾性により丸まる特性を有する弾性部材により形成されている。
(Modification 5)
FIG. 10 is a central longitudinal cross-sectional side view showing the lumen passage confirmation capsule 20B of Modification 5, and FIG. 11 is a cross-sectional view showing a state of deformation of the divided non-dissolving part. As shown in FIG. 10A, the lumen passage confirmation capsule 20B according to the modified example 5 includes a second non-dissolving portion 16 made of a material that does not dissolve inside the non-dissolving portion 12 via the dissolving portion 13. Are provided in a substantially parallel layered manner so that the non-dissolved portion has a two-layer structure, and the second non-dissolved portion 16 is also provided in a part of the second non-dissolved portion 16 as shown in FIG. A chipped portion divided into a line along the longitudinal axis direction is formed into a plurality of sheet-like members 16a, and the melted portion 13 is filled and connected to the chipped portions. As a result, the second non-dissolving part 16 divides the inside of the dissolving part (dissolving part 13 and second dissolving part 14), and a part of the surface (the chipped part) is introduced into these dissolving parts 13 and 14 from the inside. The proceeding dissolution path 17 is formed in an intermittent cross-sectional arc shape along the circumferential direction. Here, the dividing position (chip portion) of the non-dissolving portion 12 by the dissolving portion 13 and the dividing position (chip portion) of the second non-dissolving portion 16 by the dissolving portion 13 are the circumferences around the longitudinal axis of the capsule type capsule shape. It is shifted in the direction. In the modified example 5, it has shifted | deviated at equal intervals and the melt | dissolution path | route 17 is set so that it may become as long as possible equally. Further, the sheet-like members 12a and 16a constituting the non-dissolving parts 12 and 16 are formed of an elastic member having a characteristic of being rounded by elasticity.

変形例5の管腔通過確認カプセル20Bによれば、小腸内において滞留し、表層の線状の溶解部13が溶解すると、その溶解は、図10(b)に示すように第2の非溶解部16によって形成された断面円弧状の溶解経路17に沿って表面側から内部に進行する。そして、非溶解部12・第2の非溶解部16間の溶解部13が全て溶解すると、溶解部13の存在によりドーム型カプセル形状の外形を維持していた管腔通過確認カプセル20Bの非溶解部12は、ドーム型カプセル形状を維持できず、それぞれシート状部材12aに確実に分断される。その後、第2の非溶解部16の欠け部分に充填された溶解部13の溶解に移行し、この部分の溶解部13が溶解した場合に、第2の非溶解部16はシート状部材16aに分断される。   According to the lumen passage confirmation capsule 20B of the modified example 5, when the linear dissolution part 13 stays in the small intestine and the surface dissolution part 13 dissolves, the dissolution is the second non-dissolution as shown in FIG. It progresses from the surface side to the inside along the melting path 17 having a circular arc cross section formed by the portion 16. And when all the melt | dissolution parts 13 between the non-dissolution part 12 and the 2nd non-dissolution part 16 melt | dissolve, the non-dissolution of the lumen passage confirmation capsule 20B which maintained the external shape of the dome-shaped capsule shape by presence of the melt | dissolution part 13 The parts 12 cannot maintain the dome-shaped capsule shape and are reliably divided into the sheet-like members 12a. Thereafter, when the melted portion 13 filled in the chipped portion of the second non-dissolved portion 16 is melted and the melted portion 13 of this portion is melted, the second non-dissolved portion 16 is transferred to the sheet-like member 16a. Divided.

分断されたシート状部材12a,16aは、弾性によって丸まる特性を有する弾性部材からなるので、図11(a)に示すような平坦なシート状の状態から、図11(b)に示すように強制的に丸まって一層小さくなり、狭窄部等を通過しやすくなる。また、変形例5の管腔通過確認カプセル20Bの場合、第2の非溶解部16によって溶解部13の溶解に時間を要するように溶解経路17が形成されているので、溶解部13の溶解時間が例えば3日以上となるように構造的に延ばすことができ、長時間ドーム型カプセル形状を維持することができる。   Since the divided sheet-like members 12a and 16a are made of an elastic member having a property of being rounded by elasticity, the flat sheet-like state as shown in FIG. 11 (a) is forced as shown in FIG. 11 (b). As a result, it becomes rounder and smaller, and it becomes easier to pass through a constricted portion or the like. Further, in the case of the lumen passage confirmation capsule 20B of the modified example 5, the dissolution path 17 is formed by the second non-dissolving part 16 so that it takes time for the dissolving part 13 to dissolve. Can be structurally extended, for example, to be 3 days or longer, and the dome-shaped capsule shape can be maintained for a long time.

(変形例6)
図12は、変形例6の管腔通過確認カプセル20Cを示す中央縦断側面図である。変形例6の管腔通過確認カプセル20Cは、非溶解部12を渦巻状に形成し、その一部、例えば半周分がシート状の溶解部13を介して略平行かつ層状にオーバーラップするように設けたものである。ここに、表層における溶解部13の露出部は、ドーム型カプセル形状の長手軸方向に沿って線状に設けられている。また、非溶解部12のうち、内側に存在する部分は、溶解部内(第2の溶解部14と溶解部13との間)を分割して溶解部13による溶解経路17を周方向に沿うように断面円弧状に形成する第2の非溶解部18を構成している。
(Modification 6)
FIG. 12 is a central longitudinal side view showing the lumen passage confirmation capsule 20C of the sixth modification. In the lumen passage confirmation capsule 20C of the modified example 6, the non-dissolving part 12 is formed in a spiral shape, and a part thereof, for example, a half circumference overlaps substantially parallel and in layers via the sheet-like dissolving part 13. It is provided. Here, the exposed portion of the dissolving portion 13 in the surface layer is provided in a line along the longitudinal axis direction of the dome-shaped capsule shape. Moreover, the part which exists inside among the non-dissolution parts 12 divides the inside of a dissolution part (between the 2nd dissolution part 14 and dissolution part 13), and follows the dissolution path 17 by dissolution part 13 along the peripheral direction. The second non-dissolving portion 18 formed in a circular arc shape is formed.

変形例6の管腔通過確認カプセル20Cによれば、小腸内において滞留すると、溶解部13において外部に露出している表層の線状部分から溶解が始まり、断面円弧状の溶解経路17に従い内部に向けて溶解が進行する。そして、溶解経路17中の全ての溶解部13が溶解すると、内部の第2の溶解部14が短時間で溶解して空洞化するとともに、溶解部13の存在によりドーム型カプセル形状を維持していた管腔通過確認カプセル20Cの非溶解部12は、ドーム型カプセル形状を維持できず、例えば丸まって小さくなる方向に変形し、狭窄部等を通過しやすくなる。また、変形例6の管腔通過確認カプセル20Cの場合、第2の非溶解部16によって溶解部13の溶解に時間を要するように溶解経路17が形成されているので、溶解部13の溶解時間を構造的に延ばすことができ、長時間ドーム型カプセル形状を維持することができる。   According to the lumen passage confirmation capsule 20C of the modified example 6, when it stays in the small intestine, the dissolution starts from the linear portion of the surface layer that is exposed to the outside in the dissolution part 13 and enters the inside according to the dissolution path 17 having a circular arc cross section. Dissolution progresses toward. And when all the melt | dissolution parts 13 in the melt | dissolution path | route 17 melt | dissolve, while the 2nd melt | dissolution part 14 inside melt | dissolves in a short time and it cavitates, the dome-shaped capsule shape is maintained by presence of the melt | dissolution part 13. The non-dissolving portion 12 of the lumen passage confirmation capsule 20C cannot maintain the dome-shaped capsule shape, for example, is rounded and deformed in a smaller direction, and easily passes through the narrowed portion. Further, in the case of the lumen passage confirmation capsule 20C of the modified example 6, the dissolution path 17 is formed by the second non-dissolution part 16 so that the dissolution of the dissolution part 13 takes time. Can be structurally extended, and the dome-shaped capsule shape can be maintained for a long time.

(実施の形態3)
本発明の実施の形態3に係る管腔通過確認カプセルについて図13を参照して説明する。図13は、本実施の形態3に係る管腔通過確認カプセル30の構成例を示す中央縦断正面図である。本実施の形態3に係る管腔通過確認カプセル30は、体内で溶解しない材料を用いた非溶解部31が多数の微小球体31aからなり、これら多数の微小球体31aを体内で溶解する材料からなる溶解部32によって薄肉状態で数珠状に連結することにより、ドーム型カプセル形状の表層を形成するように成型したものである。これにより、溶解部32は、非溶解部31の配列に従い、ドーム型カプセル形状の長手軸方向や長手軸周りの周方向や凸形状部11a,11bにおいてあらゆる方向に線状に存在することとなる。なお、非溶解部31や溶解部32の材料は、実施の形態1,2等で説明した場合と同様のものでよい。また、非溶解部31の内部には、第2の溶解部14や被認識部15が適宜内蔵されている。
(Embodiment 3)
A lumen passage confirmation capsule according to Embodiment 3 of the present invention will be described with reference to FIG. FIG. 13 is a central longitudinal sectional front view showing a configuration example of the lumen passage confirmation capsule 30 according to the third embodiment. In the lumen passage confirmation capsule 30 according to the third embodiment, the non-dissolving portion 31 using a material that does not dissolve in the body includes a large number of microspheres 31a, and includes a material that dissolves the large number of microspheres 31a in the body. It is molded so as to form a dome-shaped capsule-shaped surface layer by connecting it in a bead shape in a thin state by the dissolving portion 32. Thereby, the melt | dissolution part 32 will exist linearly in all directions in the longitudinal direction of a dome-shaped capsule shape, the circumferential direction around a longitudinal axis, and the convex-shaped parts 11a and 11b according to the arrangement | sequence of the non-dissolution part 31. . The material of the non-dissolving part 31 and the dissolving part 32 may be the same as that described in the first and second embodiments. In addition, the second dissolving portion 14 and the recognized portion 15 are appropriately incorporated inside the non-dissolving portion 31.

本実施の形態3の管腔通過確認カプセル30によれば、小腸内において滞留すると、表層に露出している溶解部32から溶解が始まる。この際、溶解部32は各微小球体31a間を埋めるように部分的に設けられているため、溶解部32が体液に接触する面が小さく、溶解に時間がかかり、ドーム型カプセル形状を構造的に長時間維持させることができる。また、各微小球体31a周りの溶解部32の溶解の進行程度に差が生じて一部の微小球体31aが表層から分離・脱落することがあっても、溶解部32によって連結されている残りの微小球体31a部分はドーム型カプセル形状が崩壊することがない。よって、部分的に凹凸は生ずるものの、ドーム型カプセル形状を構造的に長時間維持させることができる。その後、大半の溶解部32が溶解すると、溶解部32によってドーム型カプセル形状を維持していた非溶解部31は微小球体31a間の連結状態がなくなり、個々の微小球体31aに分解される状態となり、小さくなる方向に変形する。個々に分解された微小球体31aは、狭窄部等であっても通過は容易となる。また、被検者が排便した便の中にこの微小球体31aが含まれていると、一定時間以上体腔内に管腔通過確認カプセル30が滞留していたことを示す指標になり、X線などによる滞留確認の省略も可能となる。   According to the lumen passage confirmation capsule 30 of the third embodiment, when it stays in the small intestine, dissolution starts from the dissolution part 32 exposed to the surface layer. At this time, since the dissolving portion 32 is partially provided so as to fill the space between the microspheres 31a, the surface where the dissolving portion 32 contacts the body fluid is small, it takes time to dissolve, and the dome-shaped capsule shape is structurally Can be maintained for a long time. In addition, even if there is a difference in the degree of progress of dissolution of the dissolving portions 32 around each microsphere 31a and some of the microspheres 31a may be separated from or dropped from the surface layer, the remaining portions connected by the dissolving portion 32 will remain. The dome-shaped capsule shape does not collapse in the microsphere 31a portion. Therefore, although the unevenness is partially generated, the dome-shaped capsule shape can be structurally maintained for a long time. After that, when most of the dissolving parts 32 are dissolved, the non-dissolving part 31 that has maintained the dome-shaped capsule shape by the dissolving part 32 loses the connection state between the microspheres 31a and is in a state of being decomposed into individual microspheres 31a. , It deforms in a smaller direction. Individually disassembled microspheres 31a are easy to pass even in a constricted portion or the like. Further, if the microsphere 31a is included in the stool that the subject defecates, it becomes an index indicating that the lumen passage confirmation capsule 30 has stayed in the body cavity for a certain period of time, such as X-rays. It is also possible to omit the stay confirmation.

(変形例7)
図14は、変形例7の管腔通過確認カプセル30Aを示す部分断面図である。変形例7の管腔通過確認カプセル30Aは、非溶解部31を構成する多数の微小球体31aを連結用の溶解部32を介して複数層、例えば2層に積層させて層状に設けたものである。変形例7の管腔通過確認カプセル30Aによれば、小腸内に滞留して溶解部32の溶解が進行する際、表層部分の溶解部32が溶解しても下層部分の溶解部32によって表層の非溶解部31の微小球体31aの連結状態が維持される。よって、ドーム型カプセル形状を構造的に長時間維持させることができる。その後、下層部分の溶解部32が溶解すると、表層の微小球体31aが個々に分解される状態となり、一回り小さなドーム型カプセル形状となる。さらに、残りの溶解部32が溶解すると、下層の微小球体31aも個々に分解される状態となり、小さくなる方向に変形する。なお、図14は、2層の積層例を示したが、層の数や各層内の微小球体31aの大きさや溶解部32に対する微小球体31aの割合は所望の溶解時間により適宜変形実施が可能である。
(Modification 7)
FIG. 14 is a partial cross-sectional view showing a lumen passage confirmation capsule 30A of Modification 7. The lumen passage confirmation capsule 30A of the modified example 7 is formed by laminating a large number of microspheres 31a constituting the non-dissolving part 31 into a plurality of layers, for example, two layers through the connecting dissolving part 32. is there. According to the lumen passage confirmation capsule 30A of the modified example 7, when dissolution of the dissolution part 32 proceeds in the small intestine, even if the dissolution part 32 of the surface layer part dissolves, the dissolution part 32 of the lower layer part causes the surface layer to dissolve. The connected state of the microspheres 31a of the non-dissolving part 31 is maintained. Therefore, the dome-shaped capsule shape can be structurally maintained for a long time. After that, when the dissolution part 32 of the lower layer part is dissolved, the microspheres 31a on the surface layer are individually decomposed to form a slightly dome-shaped capsule shape. Further, when the remaining dissolving portion 32 is dissolved, the lower microspheres 31a are also individually decomposed and deformed in a smaller direction. Although FIG. 14 shows an example of a two-layer stack, the number of layers, the size of the microspheres 31a in each layer, and the ratio of the microspheres 31a to the dissolution part 32 can be appropriately modified depending on the desired dissolution time. is there.

(実施の形態4)
本発明の実施の形態4に係る管腔通過確認カプセルについて図15を参照して説明する。図15は、本実施の形態4に係る管腔通過確認カプセル40を示す縦断正面図である。本実施の形態4に係る管腔通過確認カプセル40は、溶解部41と、非溶解部42と、被認識部15により構成されている。
(Embodiment 4)
A lumen passage confirmation capsule according to Embodiment 4 of the present invention will be described with reference to FIG. FIG. 15 is a longitudinal front view showing the lumen passage confirmation capsule 40 according to the fourth embodiment. The lumen passage confirmation capsule 40 according to the fourth embodiment includes a dissolving part 41, a non-dissolving part 42, and a recognized part 15.

溶解部41は、体内で溶解する材料からなり、ドーム型カプセル形状の構造体をなすものである。この溶解部41を構成する材料は、前述の実施の形態の場合と同様の腸溶性材料が用いられている。また、非溶解部42は、脆く、機械的強度が無く、単体ではその形状を維持することができない特性を有し、基本的に体内で溶解しない材料、例えば金などの金属薄膜等からなり、カプセル形状の構造体をなす溶解部41の一部を開口部43によって表面に露出させて溶解部41の表面を覆う薄膜として形成されている。開口部43は、例えば長手軸方向の両端の凸形状部11a,11bの中央部分に形成されている。また、非溶解部42は、溶解部41に固着した状態で設けられている。これにより、非溶解部42はカプセル形状を維持することができる。   The dissolution part 41 is made of a material that dissolves in the body and forms a dome-shaped capsule-shaped structure. As the material constituting the dissolving portion 41, the same enteric material as in the above-described embodiment is used. In addition, the non-dissolving part 42 is brittle, has no mechanical strength, has a characteristic that the shape cannot be maintained alone, and is basically made of a material that does not dissolve in the body, for example, a metal thin film such as gold, A part of the dissolving part 41 forming a capsule-shaped structure is exposed to the surface by the opening 43 and is formed as a thin film covering the surface of the dissolving part 41. The opening 43 is formed, for example, at the center of the convex portions 11a and 11b at both ends in the longitudinal axis direction. Further, the non-dissolving part 42 is provided in a state of being fixed to the dissolving part 41. Thereby, the non-dissolving part 42 can maintain a capsule shape.

このような構成の管腔通過確認カプセル40は、小腸内に滞留すると、図15(b)に示すように、溶解部41は開口部43によって外部に露出している部分から内部に向けて溶解が徐々に進行する。この間、表層の非溶解部42は、内部の溶解部41と一体となってドーム型カプセル形状を維持している。その後、一定時間が経過して内部の大半の溶解部41が溶解して空洞化すると、溶解部41はドーム型カプセル形状を維持できなくなり崩壊する。このとき、薄膜による非溶解部42も自身ではドーム型カプセル形状を維持できないため、溶解部41の崩壊とほぼ同時にばらばらに崩壊することとなり、狭窄部等であっても通過し得ることとなる。   When the lumen passage confirmation capsule 40 having such a configuration stays in the small intestine, as shown in FIG. 15B, the dissolving portion 41 is dissolved from the portion exposed to the outside through the opening 43 toward the inside. Gradually progresses. During this time, the non-dissolving part 42 on the surface layer is integrated with the internal dissolving part 41 to maintain a dome-shaped capsule shape. After that, when a certain period of time has passed and most of the melting portion 41 inside has melted and hollowed out, the melting portion 41 cannot maintain the dome-shaped capsule shape and collapses. At this time, the non-dissolving portion 42 made of a thin film itself cannot maintain the dome-shaped capsule shape, and therefore, the disintegrating portion 41 is disintegrated almost simultaneously with the disintegration of the dissolving portion 41, and even a constricted portion or the like can pass through.

ここで、本実施の形態4に係る管腔通過確認カプセル40の製造方法を説明する。第1の例としては、まず、体内で溶解する溶解部41をドーム型カプセル形状なる構造体として形成する工程を行い、次いで、溶解部41からなる構造体の一部(開口部43)を除いて、体内で溶解しない非溶解部42の薄膜を形成する工程を行うことで製造される。このとき、非溶解部42の薄膜は、溶解部41の表面に固着される。   Here, a manufacturing method of the lumen passage confirmation capsule 40 according to the fourth embodiment will be described. As a first example, first, a process of forming a dissolving part 41 that dissolves in the body as a dome-shaped capsule-shaped structure is performed, and then a part of the structure (opening 43) including the dissolving part 41 is removed. Thus, it is manufactured by performing a step of forming a thin film of the non-dissolving portion 42 that does not dissolve in the body. At this time, the thin film of the non-dissolving part 42 is fixed to the surface of the dissolving part 41.

第2の例としては、まず、体内で溶解する溶解部41をドーム型カプセル形状なる構造体として形成する工程を行い、次いで、溶解部41からなる構造体の表面全面に体内で溶解しない非溶解部42の薄膜を形成・固着する工程を行い、さらに、非溶解部42による薄膜の一部(開口部43)を取り除く工程を行うことで製造される。   As a second example, first, the step of forming the dissolving portion 41 that dissolves in the body as a dome-shaped capsule-shaped structure is performed, and then the non-dissolving that does not dissolve in the body on the entire surface of the structure including the dissolving portion 41 It is manufactured by performing a process of forming and fixing the thin film of the part 42 and further removing a part of the thin film (opening 43) by the non-dissolving part 42.

溶解部41からなる構造体の表面に非溶解部42の薄膜を形成する工程としては、非溶解部42を構成する材料を蒸着する方法や、吹き付けた後に硬化させる方法であってもよい。また、非溶解部42として液状の材料を用い、この液状の材料中に溶解部41からなる構造体を浸した後に取り出し、硬化させる方法であってもよい。また、第1の例における溶解部41からなる構造体の一部を除いて非溶解部42の薄膜を形成する工程としては、溶解部41からなる構造体の表面にマスキングを行い、表面に薄膜形成後にマスキング部分を取り除くことで、マスキングされていない部分のみに非溶解部42の薄膜を形成することで実現できる。ここで、被認識部15は、X線不透過性の金属やバリウムであればよい。また、非溶解部42または溶解部41が、X線不透過性を有し、被認識部15を兼ねるようにしてもよい。この場合、構造が単純化され、製造が容易になるとともに、X線で溶解状態を確認することができる。   The step of forming the thin film of the non-dissolving part 42 on the surface of the structure composed of the dissolving part 41 may be a method of vapor-depositing a material constituting the non-dissolving part 42 or a method of curing after spraying. Alternatively, a method may be used in which a liquid material is used as the non-dissolving portion 42 and the structure made of the dissolving portion 41 is immersed in the liquid material and then taken out and cured. Moreover, as a process of forming a thin film of the non-dissolved portion 42 except for a part of the structure composed of the dissolved portion 41 in the first example, masking is performed on the surface of the structure composed of the dissolved portion 41, and a thin film is formed on the surface. By removing the masking portion after the formation, the thin film of the non-dissolved portion 42 can be formed only in the unmasked portion. Here, the recognizable portion 15 may be a radiopaque metal or barium. Further, the non-dissolving part 42 or the dissolving part 41 may be radiopaque and serve also as the recognized part 15. In this case, the structure is simplified, the manufacture is facilitated, and the dissolved state can be confirmed by X-rays.

(変形例8)
図16は、変形例8の管腔通過確認カプセル40Aを示す縦断正面図である。変形例8の管腔通過確認カプセル40Aは、溶解部41からなる構造体の表面に非溶解部42による薄膜を42a,42b,42cで示す如く、多重、例えば三重に形成したものである。変形例8の管腔通過確認カプセル40Aによれば、嚥下前もしくは体腔内で管腔通過確認カプセル40aの表面に傷がつくようなことがあっても、多重構造の非溶解部42a,42b,42cによって内部の溶解部41まで露出してしまうことが防止される。よって、開口部43以外の部分から溶解部41の溶解が進行することがなく、ドーム型カプセル形状を維持できなくなる時間が短縮されてしまうことを防止できる。
(Modification 8)
FIG. 16 is a longitudinal front view showing a lumen passage confirmation capsule 40A of Modification 8. The lumen passage confirmation capsule 40A according to the modified example 8 is formed by forming multiple thin films, for example, triple layers, as indicated by 42a, 42b, and 42c on the surface of the structure formed by the dissolved portion 41 as indicated by 42a, 42b, and 42c. According to the lumen passage confirmation capsule 40A of the modified example 8, even if the surface of the lumen passage confirmation capsule 40a is damaged before swallowing or in the body cavity, the non-dissolving parts 42a, 42b, 42c prevents the inner dissolution part 41 from being exposed. Therefore, the dissolution of the dissolving portion 41 does not proceed from a portion other than the opening 43, and it is possible to prevent the time during which the dome-shaped capsule shape cannot be maintained from being shortened.

変形例8の管腔通過確認カプセル40Aを製造する場合、まず、体内で溶解する溶解部41をドーム型カプセル形状なる構造体として形成する工程を行った後、溶解部41からなる構造体の一部(開口部43)を除いて、体内で溶解しない非溶解部42の薄膜を形成・固着する工程を必要回数繰り返して行うことで製造される。ここで、溶解部41をドーム型カプセル形状なる構造体として形成する工程を行う際、目的とするドーム型カプセル形状の大きさよりも一回り小さな大きさに形成しておくことで、最終的に製造される管腔通過確認カプセル40Aの大きさを目的とするドーム型カプセル形状の大きさに合わせることができる。また、溶解部41の表面に非溶解部42を形成するときは、溶解部41と非溶解部42が固着し、非溶解部42の表面に非溶解部42を形成するときは、非溶解部42同士が固着するようにする。   When manufacturing the lumen passage confirmation capsule 40A of the modified example 8, first, after performing the step of forming the dissolving portion 41 that dissolves in the body as a dome-shaped capsule-shaped structure, It is manufactured by repeating the process of forming and fixing the thin film of the non-dissolved part 42 that does not dissolve in the body except the part (opening 43). Here, when performing the step of forming the melting portion 41 as a dome-shaped capsule-shaped structure, it is finally manufactured by forming it in a size slightly smaller than the size of the target dome-shaped capsule shape. The size of the lumen passage confirmation capsule 40A can be adjusted to the size of the target dome-shaped capsule shape. Further, when the non-dissolving part 42 is formed on the surface of the dissolving part 41, the dissolving part 41 and the non-dissolving part 42 are fixed, and when the non-dissolving part 42 is formed on the surface of the non-dissolving part 42, the non-dissolving part 42 42 are fixed to each other.

なお、本実施の形態4や変形例8に係る管腔通過確認カプセル40,40Aの場合、溶解部41がドーム型カプセル形状の構造体をなすようにしたが、非溶解部42側をドーム型カプセル形状の構造体をなすように例えば柔軟性を有するような薄肉状に設けた場合であっても同様に適用することができる。このとき、非溶解部42は、溶解部41が溶解後、潰れることで小さくなる。   In the case of the lumen passage confirmation capsules 40 and 40A according to the fourth embodiment and the modification 8, the dissolving portion 41 is formed as a dome-shaped capsule-shaped structure, but the non-dissolving portion 42 side is a dome shape. The present invention can be similarly applied even when it is provided in a thin-walled shape having flexibility, for example, so as to form a capsule-shaped structure. At this time, the non-dissolving part 42 becomes small by being crushed after the dissolving part 41 is dissolved.

(実施の形態5)
本発明の実施の形態5に係る管腔通過確認カプセルについて図17および図18を参照して説明する。図17は、本実施の形態5に係る管腔通過確認カプセル50の構成例を示す縦断正面図であり、図18はその側面図である。
(Embodiment 5)
A lumen passage confirmation capsule according to Embodiment 5 of the present invention will be described with reference to FIGS. 17 and 18. FIG. 17 is a longitudinal front view showing a configuration example of the lumen passage confirmation capsule 50 according to the fifth embodiment, and FIG. 18 is a side view thereof.

本実施の形態5に係る管腔通過確認カプセル50は、ドーム型カプセル形状の構造体をなす溶解部41の軸心に位置させて長手軸方向に貫通させた貫通孔51を形成し、この貫通孔51内の一部、本実施の形態5では長手軸方向の中央の開口部52を除いて、溶解部41の内側表面に第2の非溶解部53を設けたものである。ここで、体内で溶解しない材料からなる第2の非溶解部53の長手軸方向の端部53aは、ドーム型カプセル形状の表面において非溶解部42の端部42aと一体となるように繋がっている。また、第2の非溶解部53は、非溶解部42と同一材料であってもよく、異なる材料であってもよい。さらに、管腔通過確認カプセル50内に内蔵される被認識部15は、溶解部41内において開口部52から最も遠い長手軸方向の両端最奥部に被認識部15a,15bとして分割されて離間配置されている。このとき、非溶解部42,53は、脆く、機械的強度を有しない特性を有し、溶解部41に固着させた状態で形成される。   The lumen passage confirmation capsule 50 according to the fifth embodiment is formed with a through-hole 51 that is located in the axial center of the dissolving portion 41 that forms a dome-shaped capsule-shaped structure and penetrates in the longitudinal axis direction. In the fifth embodiment, the second non-dissolving portion 53 is provided on the inner surface of the dissolving portion 41 except for the central opening portion 52 in the longitudinal axis direction in part of the hole 51. Here, the end 53a in the longitudinal axis direction of the second non-dissolving portion 53 made of a material that does not dissolve in the body is connected to be integrated with the end 42a of the non-dissolving portion 42 on the surface of the dome-shaped capsule. Yes. Further, the second non-dissolving part 53 may be the same material as the non-dissolving part 42 or may be a different material. Furthermore, the recognized portion 15 incorporated in the lumen passage confirmation capsule 50 is divided and separated as recognized portions 15a and 15b at the innermost ends of the longitudinal direction farthest from the opening 52 in the dissolving portion 41. Has been placed. At this time, the non-dissolving parts 42 and 53 are brittle and have characteristics that do not have mechanical strength, and are formed in a state of being fixed to the dissolving part 41.

このような構成の管腔通過確認カプセル50は、小腸内に滞留すると、図17(b)に示すように、貫通孔51内の中央部の開口部52によって外部に露出している溶解部41部分から内部に向けて溶解が徐々に進行する。この間、表層の非溶解部42は、内部の溶解部41によってドーム型カプセル形状を維持している。その後、一定時間が経過して内部の大半の溶解部41が溶解して空洞化すると、溶解部41はドーム型カプセル形状を維持できなくなり崩壊する。このとき、薄膜による非溶解部42も自身ではドーム型カプセル形状を維持できないため、溶解部41の崩壊とほぼ同時にばらばらに崩壊することとなり、狭窄部等であっても通過し得ることとなる。また、溶解部41、非溶解部42,53の崩壊により、被認識部15a,15bもばらばらになって狭窄部等を通過し排出される。   When the lumen passage confirmation capsule 50 having such a configuration stays in the small intestine, as shown in FIG. 17B, the dissolution part 41 exposed to the outside through the central opening 52 in the through hole 51. Dissolution proceeds gradually from the part toward the inside. During this time, the non-dissolving part 42 on the surface layer maintains a dome-shaped capsule shape by the dissolving part 41 inside. After that, when a certain period of time has passed and most of the melting portion 41 inside has melted and hollowed out, the melting portion 41 cannot maintain the dome-shaped capsule shape and collapses. At this time, the non-dissolving portion 42 made of a thin film itself cannot maintain the dome-shaped capsule shape, and therefore, the disintegrating portion 41 is disintegrated almost simultaneously with the disintegration of the dissolving portion 41, and even a constricted portion or the like can pass through. Further, due to the collapse of the dissolving portion 41 and the non-dissolving portions 42 and 53, the recognized portions 15a and 15b are also separated and discharged through the narrowed portion and the like.

本実施の形態5に係る管腔通過確認カプセル50によれば、ドーム型カプセル形状の維持に関係ない部分として貫通孔51を介して中央内部に形成された開口部52から溶解部41の溶解が進行するので、構造的に長時間カプセル形状を維持させることができる。また、非溶解部42の端部42aも第2の非溶解部53の端部53aに繋がって連続的に保護されているため、非溶解部42の端部42a付近から溶解部41が溶解することによるカプセル形状の崩壊を生ずることがなく、この点でも、構造的に長時間カプセル形状を維持させることができる。   According to the lumen passage confirmation capsule 50 according to the fifth embodiment, the dissolving portion 41 is dissolved from the opening 52 formed in the center through the through hole 51 as a portion not related to the maintenance of the dome-shaped capsule shape. Since it proceeds, the capsule shape can be maintained structurally for a long time. Further, since the end portion 42 a of the non-dissolving portion 42 is also continuously protected by being connected to the end portion 53 a of the second non-dissolving portion 53, the dissolving portion 41 is dissolved from the vicinity of the end portion 42 a of the non-dissolving portion 42. In this respect, the capsule shape can be maintained for a long time.

また、本実施の形態5に係る管腔通過確認カプセル50によれば、被認識部15が被認識部15a,15bとして分割されて離間配置されているので、一定時間以上経過後に認識装置を用いて被認識部15a,15bの存在の有無を確認する上で、カプセル状態を確認することができる。すなわち、認識される被認識部15a,15bの状態がばらばらであれば、管腔通過確認カプセル50が管腔内で崩壊した状態にあると判断できる一方、認識される被認識部15a,15bの状態が当初の離間配置の状態のままであれば、管腔通過確認カプセル50が管腔内で崩壊することなく滞留している状態にあると判断することができる。特に、被認識部15a,15bが開口部52から最も遠い最奥部に配置されているので、管腔通過確認カプセル50が最終的に崩壊するまで、被認識部15a,15bの位置関係を維持することができ、管腔内における管腔通過確認カプセル50の崩壊の有無を適正に判断することができる。また、被認識部は、X線が不透過であって腸内で非溶解な金属でもよいし、腸内で溶解可能なバリウムでもよい。また、実施の形態4と同様に、溶解部41、非溶解部42,53がX線不透過性を有し、被認識部15を兼ねてもよい。   In addition, according to the lumen passage confirmation capsule 50 according to the fifth embodiment, the recognition unit 15 is divided and separated as the recognition units 15a and 15b, so that the recognition device is used after a predetermined time or more has elapsed. Thus, the capsule state can be confirmed when the presence or absence of the recognized portions 15a and 15b is confirmed. That is, if the recognized recognized portions 15a and 15b are in different states, it can be determined that the lumen passage confirmation capsule 50 is in a collapsed state in the lumen, while the recognized recognized portions 15a and 15b If the state remains in the initially spaced state, it can be determined that the lumen passage confirmation capsule 50 is staying in the lumen without collapsing. In particular, since the recognized portions 15a and 15b are arranged at the innermost portion farthest from the opening 52, the positional relationship between the recognized portions 15a and 15b is maintained until the lumen passage confirmation capsule 50 is finally collapsed. Therefore, the presence or absence of the collapse of the lumen passage confirmation capsule 50 in the lumen can be appropriately determined. Further, the recognized portion may be a metal that does not transmit X-rays and is not dissolved in the intestine, or may be barium that can be dissolved in the intestine. Similarly to the fourth embodiment, the dissolving portion 41 and the non-dissolving portions 42 and 53 may have radiopacity and may also serve as the recognized portion 15.

なお、本実施の形態5に係る管腔通過確認カプセル50の場合、溶解部41がドーム型カプセル形状の構造体をなすようにしたが、非溶解部42側をドーム型カプセル形状の構造体をなすように例えば柔軟性を有するような薄肉状に設けた場合であっても同様に適用することができる。このとき、非溶解部42は、溶解部41が溶解後、潰れることで小さくなる。   In the case of the lumen passage confirmation capsule 50 according to the fifth embodiment, the dissolving part 41 forms a dome-shaped capsule-shaped structure, but the non-dissolving part 42 side is replaced with a dome-shaped capsule-shaped structure. For example, even if it is provided in a thin wall shape having flexibility, it can be similarly applied. At this time, the non-dissolving part 42 becomes small by being crushed after the dissolving part 41 is dissolved.

(実施の形態6)
本発明の実施の形態6に係る管腔通過確認カプセルについて図19を参照して説明する。図19は、本実施の形態6に係る管腔通過確認カプセル60の構成例を示す縦断正面図である。
(Embodiment 6)
A lumen passage confirmation capsule according to Embodiment 6 of the present invention will be described with reference to FIG. FIG. 19 is a longitudinal front view showing a configuration example of the lumen passage confirmation capsule 60 according to the sixth embodiment.

本実施の形態6に係る管腔通過確認カプセル60は、ドーム型カプセル形状の構造体をなす溶解部41に対して長手軸中心方向に伸展するように設けられて、溶解部41内を長手軸方向に沿って円筒状に分割して、溶解部41中に表面の一部である外側の開口部43から内側中央の開口部61を経て内部に進行する溶解経路62を形成する第2の非溶解部63を備える。ここで、体内で溶解しない材料からなる第2の非溶解部63の長手軸方向の端部63aは、ドーム型カプセル形状の表面において非溶解部42の端部42aと一体となるように繋がっている。また、第2の非溶解部63は、非溶解部42と同一材料であってもよく、異なる材料であってもよい。さらに、管腔通過確認カプセル60内に内蔵される被認識部15は、溶解部41内において溶解経路62の両端最奥部に被認識部15a,15bとして分割されて離間配置されている。このとき、非溶解部42,63は、脆く、機械的強度を有しない特性を有し、溶解部41に固着させた状態で形成される。   The lumen passage confirmation capsule 60 according to the sixth embodiment is provided so as to extend in the central direction of the longitudinal axis with respect to the dissolving portion 41 forming the dome-shaped capsule-shaped structure, and the inside of the dissolving portion 41 is moved to the longitudinal axis. A second non-dividing part that is divided into a cylindrical shape along the direction to form a dissolution path 62 that progresses inward from the outer opening 43 that is a part of the surface through the inner central opening 61 in the melting part 41. A melting part 63 is provided. Here, the end 63a in the longitudinal axis direction of the second non-dissolving portion 63 made of a material that does not dissolve in the body is connected so as to be integrated with the end 42a of the non-dissolving portion 42 on the surface of the dome-shaped capsule. Yes. The second non-dissolving part 63 may be the same material as the non-dissolving part 42 or may be a different material. Further, the recognized portion 15 incorporated in the lumen passage confirmation capsule 60 is divided and separated as recognized portions 15 a and 15 b at the innermost end of the dissolving path 62 in the dissolving portion 41. At this time, the non-dissolving parts 42 and 63 are brittle, have a characteristic that does not have mechanical strength, and are formed in a state of being fixed to the dissolving part 41.

本実施の形態6に係る管腔通過確認カプセル60は、円柱状に形成した溶解部41aの表面に開口部43,61部分を除いて第2の非溶解部63を設け、さらにその表面に溶解部41bを所望のドーム型カプセル形状に設けて構造体をなし、この構造体の表面に非溶解部42を薄膜形成・固着することにより製造される。   The lumen passage confirmation capsule 60 according to the sixth embodiment is provided with a second non-dissolving portion 63 except for the openings 43 and 61 on the surface of the dissolving portion 41a formed in a columnar shape, and further dissolving on the surface. The part 41b is formed in a desired dome-shaped capsule shape to form a structure, and the non-dissolved part 42 is formed and fixed on the surface of the structure.

このような構成の管腔通過確認カプセル60は、小腸内に滞留すると、図19(b)に示すように、開口部43によって外部に露出している溶解部41部分から溶解が始まり、溶解経路62に従い第2の非溶解部63内を進行し、さらには開口部61を経て第2の非溶解部63外に進行する。この間、表層の非溶解部42は、内部の溶解部41によってドーム型カプセル形状を維持している。その後、一定時間が経過して内部の大半の溶解部41が溶解して空洞化すると、溶解部41はドーム型カプセル形状を維持できなくなり崩壊する。このとき、薄膜による非溶解部42も自身ではドーム型カプセル形状を維持できないため、溶解部41の崩壊とほぼ同時にばらばらに崩壊することとなり、狭窄部等であっても通過し得ることとなる。また、溶解部41、非溶解部42,63の崩壊により、被認識部15a,15bもばらばらになって狭窄部等を通過し排出される。   When the lumen passage confirmation capsule 60 having such a configuration stays in the small intestine, as shown in FIG. 19B, dissolution starts from the dissolution portion 41 exposed to the outside through the opening 43, and the dissolution route It proceeds in the second non-dissolving part 63 according to 62, and further proceeds to the outside of the second non-dissolving part 63 through the opening 61. During this time, the non-dissolving part 42 on the surface layer maintains a dome-shaped capsule shape by the dissolving part 41 inside. After that, when a certain period of time has passed and most of the melting portion 41 inside has melted and hollowed out, the melting portion 41 cannot maintain the dome-shaped capsule shape and collapses. At this time, the non-dissolving portion 42 made of a thin film itself cannot maintain the dome-shaped capsule shape, and therefore, the disintegrating portion 41 is disintegrated almost simultaneously with the disintegration of the dissolving portion 41, and even a constricted portion or the like can pass through. In addition, due to the collapse of the dissolving portion 41 and the non-dissolving portions 42 and 63, the recognized portions 15a and 15b are also separated and discharged through the constricted portion and the like.

本実施の形態6に係る管腔通過確認カプセル60によれば、溶解部41内を第2の非溶解部63によって分割して溶解部41中に表面の一部から内部に進行する溶解経路62を形成しているので、溶解経路62を長くすることで溶解部41が管腔内で溶解する時間が例えば3日以上となるように構造的に長くすることができ、よって、カプセル形状を長時間維持することができる。よって、通過性を確認するために必要な一定時間、カプセル形状を確実に維持することができ、管腔通過性を確実に確認することができる。特に、溶解経路62を形成する第2の非溶解部63をドーム型カプセル形状の中心方向に伸展するように設けているので、ドーム型カプセル形状の維持に関係ない部分が先に溶解するようにドーム型カプセル形状の中心部分から外側に向けて溶解部41を溶解させる溶解経路62を形成することができ、ドーム型カプセル形状の外表面をなす非溶解部42近傍の溶解部41が溶解するまでの時間を長くすることができる。また、非溶解部42の端部42aも第2の非溶解部63の端部63aに繋がって連続的に保護されているため、非溶解部42の端部42a付近から溶解部41が溶解することによるカプセル形状の崩壊を生ずることがなく、この点でも、構造的に長時間カプセル形状を維持させることができる。また、溶解経路62によって長時間カプセル形状を維持できるので、溶解部41に使用できる素材の選択肢が広がり、製造の簡略化、低コスト化が可能となる。   According to the lumen passage confirmation capsule 60 according to the sixth embodiment, the dissolution path 62 is divided into the dissolution part 41 by the second non-dissolution part 63 and proceeds from a part of the surface into the dissolution part 41. Therefore, by increasing the length of the dissolution path 62, the dissolution time of the dissolution part 41 in the lumen can be structurally increased, for example, to be 3 days or longer. Can be maintained for hours. Therefore, the capsule shape can be reliably maintained for a certain period of time necessary for confirming passage, and lumen passage can be confirmed with certainty. In particular, since the second non-dissolving portion 63 forming the dissolution path 62 is provided so as to extend in the center direction of the dome-shaped capsule shape, the portion not related to the maintenance of the dome-shaped capsule shape is dissolved first. It is possible to form a dissolution path 62 for dissolving the dissolving portion 41 from the center portion of the dome-shaped capsule shape toward the outside, and until the dissolving portion 41 in the vicinity of the non-dissolving portion 42 forming the outer surface of the dome-shaped capsule shape is dissolved. Can be lengthened. Further, since the end portion 42a of the non-dissolving portion 42 is also continuously protected by being connected to the end portion 63a of the second non-dissolving portion 63, the dissolving portion 41 is dissolved from the vicinity of the end portion 42a of the non-dissolving portion 42. In this respect, the capsule shape can be maintained for a long time. Further, since the capsule shape can be maintained for a long time by the dissolution path 62, the choices of materials that can be used for the dissolution part 41 are widened, and manufacturing can be simplified and the cost can be reduced.

また、本実施の形態6に係る管腔通過確認カプセル60によれば、実施の形態5の場合と同様に、被認識部15が被認識部15a,15bとして分割されて離間配置されているので、一定時間以上経過後に認識装置を用いて被認識部15a,15bの存在の有無を確認する上で、カプセル状態を確認することができる。すなわち、認識される被認識部15a,15bの状態がばらばらであれば、管腔通過確認カプセル60が管腔内で崩壊した状態にあると判断できる一方、認識される被認識部15a,15bの状態が当初の離間配置の状態のままであれば、管腔通過確認カプセル60が管腔内で崩壊することなく滞留している状態にあると判断することができる。特に、被認識部15a,15bが溶解経路62の最奥部に配置されているので、管腔通過確認カプセル60が最終的に崩壊するまで、被認識部15a,15bの位置関係を維持することができ、管腔内における管腔通過確認カプセル60の崩壊の有無を適正に判断することができる。また、被認識部は、X線が不透過であって腸内で非溶解な金属でもよいし、腸内で溶解可能なバリウムでもよい。また、実施の形態4と同様に、溶解部41、非溶解部42,63がX線不透過性を有し、被認識部15を兼ねてもよい。   Further, according to the lumen passage confirmation capsule 60 according to the sixth embodiment, as in the case of the fifth embodiment, the recognized portion 15 is divided and disposed as the recognized portions 15a and 15b. When the presence / absence of the recognized portions 15a and 15b is confirmed using the recognition device after a predetermined time or more has elapsed, the capsule state can be confirmed. That is, if the recognized parts 15a and 15b are in different states, it can be determined that the lumen passage confirmation capsule 60 is in a collapsed state in the lumen, while the recognized parts 15a and 15b are recognized. If the state remains in the initially spaced state, it can be determined that the lumen passage confirmation capsule 60 is in a state of staying without collapsing in the lumen. In particular, since the recognized parts 15a and 15b are arranged at the innermost part of the dissolution path 62, the positional relationship between the recognized parts 15a and 15b is maintained until the lumen passage confirmation capsule 60 is finally collapsed. Therefore, the presence or absence of the collapse of the lumen passage confirmation capsule 60 in the lumen can be properly determined. Further, the recognized portion may be a metal that does not transmit X-rays and is not dissolved in the intestine, or may be barium that can be dissolved in the intestine. Similarly to the fourth embodiment, the dissolving portion 41 and the non-dissolving portions 42 and 63 may have radiopacity and may also serve as the recognized portion 15.

(変形例9)
図20は、変形例9の管腔通過確認カプセル60Aを示す縦断正面図である。変形例9の管腔通過確認カプセル60Aは、溶解部41内において円筒状の第2の非溶解部63の外側に体内で溶解しない材料からなる円筒状の第3の非溶解部64を設けることで、溶解経路62をさらに分割して細分化したものである。ここで、第3の非溶解部64は、開口部61周りを含む中央部周りに設けられ、溶解経路62が開口部43→第2の非溶解部63内→開口部61→第2、第3の非溶解部63,64間→第3の非溶解部64・非溶解部42間となるように設定されている。変形例9の管腔通過確認カプセル60Aによれば、溶解経路62が細分化によりさらに長くなるように形成されているので、溶解部41が溶解するのに要する時間を構造的に延ばすことができ、より一層長時間ドーム型カプセル形状を維持することができる。また、溶解経路62によって長時間カプセル形状を維持できるので、溶解部41に使用できる素材の選択肢が広がり、製造の簡略化、低コスト化が可能となる。
(Modification 9)
FIG. 20 is a longitudinal front view showing a lumen passage confirmation capsule 60A of the ninth modification. The lumen passage confirmation capsule 60A of the modification 9 is provided with a cylindrical third non-dissolving portion 64 made of a material that does not dissolve in the body outside the cylindrical second non-dissolving portion 63 in the dissolving portion 41. The dissolution path 62 is further divided and subdivided. Here, the third non-dissolving portion 64 is provided around the central portion including the periphery of the opening 61, and the dissolution path 62 is formed in the opening 43 → the second non-dissolving portion 63 → the opening 61 → the second and second. The distance between the third non-dissolving part 63 and 64 is set to be between the third non-dissolving part 64 and the non-dissolving part 42. According to the lumen passage confirmation capsule 60A of the modified example 9, since the dissolution path 62 is formed to be longer by subdivision, the time required for the dissolution part 41 to dissolve can be structurally extended. The dome-shaped capsule shape can be maintained for a longer time. Further, since the capsule shape can be maintained for a long time by the dissolution path 62, the choices of materials that can be used for the dissolution part 41 are widened, and manufacturing can be simplified and the cost can be reduced.

なお、本実施の形態6や変形例9に係る管腔通過確認カプセル60,60Aの場合、溶解部41がドーム型カプセル形状の構造体をなすようにしたが、非溶解部42側をドーム型カプセル形状の構造体をなすように例えば柔軟性を有するような薄肉状に設けた場合であっても同様に適用することができる。このとき、非溶解部42は、溶解部41が溶解後、潰れることで小さくなる。   In the case of the lumen passage confirmation capsules 60 and 60A according to the sixth embodiment and the modification 9, the dissolving portion 41 is formed as a dome-shaped capsule-shaped structure. The present invention can be similarly applied even when it is provided in a thin-walled shape having flexibility, for example, so as to form a capsule-shaped structure. At this time, the non-dissolving part 42 becomes small by being crushed after the dissolving part 41 is dissolved.

(実施の形態7)
本発明の実施の形態7に係る管腔通過確認カプセルについて図21を参照して説明する。図21は、本実施の形態7に係る管腔通過確認カプセル70の構成例を示す縦断正面図である。
(Embodiment 7)
A lumen passage confirmation capsule according to Embodiment 7 of the present invention will be described with reference to FIG. FIG. 21 is a longitudinal front view showing a configuration example of the lumen passage confirmation capsule 70 according to the seventh embodiment.

本実施の形態7に係る管腔通過確認カプセル70は、ドーム型カプセル形状の構造体をなす溶解部41の長手軸方向の両端に、長手軸を横切る方向に溶解部41を分割して開口部43から内部中央側に進行する溶解経路71を形成する第2の非溶解部72を櫛歯状に設けるとともに、第2の非溶解部72とは逆側から長手軸を横切る方向に溶解部41を分割して溶解経路71をさらに分割して細分化する第3の非溶解部73を櫛歯状に設けたものである。すなわち、体内で溶解しない材料からなる第2,第3の非溶解部72,73は、互い違いに入り込む櫛歯状に形成され、開口部43から開始する溶解経路71を迷路状に折り返して長く形成している。このとき、非溶解部42,72,73は、脆く、機械的強度を有しない特性を有し、溶解部41に固着させた状態で形成される。   The lumen passage confirmation capsule 70 according to the seventh embodiment has an opening portion by dividing the dissolution portion 41 in a direction crossing the longitudinal axis at both ends in the longitudinal axis direction of the dissolution portion 41 forming a dome-shaped capsule-shaped structure. The second non-dissolving portion 72 that forms the dissolution path 71 that progresses from 43 to the inner center side is provided in a comb-like shape, and the dissolving portion 41 extends in the direction across the longitudinal axis from the opposite side of the second non-dissolving portion 72 A third non-dissolving portion 73 is provided in a comb-teeth shape to further divide the dissolution path 71 and further subdivide it. That is, the second and third non-dissolving parts 72 and 73 made of a material that does not dissolve in the body are formed in a comb-tooth shape that alternately enters, and the dissolution path 71 starting from the opening 43 is folded back into a labyrinth and formed long. is doing. At this time, the non-dissolving parts 42, 72, and 73 are brittle, have characteristics that do not have mechanical strength, and are formed in a state of being fixed to the dissolving part 41.

このような構成の管腔通過確認カプセル70は、小腸内に滞留すると、開口部43によって外部に露出している溶解部41部分から溶解が始まり、迷路状に形成された溶解経路71に従い溶解部41内を進行する。この間、表層の非溶解部42は、内部の溶解部41によってドーム型カプセル形状を維持している。その後、一定時間が経過して内部の大半の溶解部41が溶解して空洞化すると、溶解部41はドーム型カプセル形状を維持できなくなり崩壊する。このとき、薄膜による非溶解部42も自身ではドーム型カプセル形状を維持できないため、溶解部41の崩壊とほぼ同時にばらばらに崩壊することとなり、狭窄部等であっても通過し得ることとなる。   When the luminal passage confirmation capsule 70 having such a structure stays in the small intestine, the dissolution starts from the dissolution portion 41 exposed to the outside by the opening 43 and follows the dissolution path 71 formed in the maze shape. Proceed through 41. During this time, the non-dissolving part 42 on the surface layer maintains a dome-shaped capsule shape by the dissolving part 41 inside. After that, when a certain period of time has passed and most of the melting portion 41 inside has melted and hollowed out, the melting portion 41 cannot maintain the dome-shaped capsule shape and collapses. At this time, the non-dissolving portion 42 made of a thin film itself cannot maintain the dome-shaped capsule shape, and therefore, the disintegrating portion 41 is disintegrated almost simultaneously with the disintegration of the dissolving portion 41, and even a constricted portion or the like can pass through.

本実施の形態7に係る管腔通過確認カプセル70によれば、溶解部41内を第2,第3の非溶解部72,73によって分割して細分化された溶解経路71を形成しているので、溶解経路71を長くすることで溶解部41が管腔内で溶解する時間を構造的に長くすることができ、よって、カプセル形状を長時間維持することができる。よって、通過性を確認するために必要な一定時間、カプセル形状を確実に維持することができ、管腔通過性を確実に確認することができる。また、被認識部は、X線が不透過であって腸内で非溶解な金属でもよいし、腸内で溶解可能なバリウムでもよい。また、実施の形態4と同様に、溶解部41、非溶解部42,72,73がX線不透過性を有し、被認識部15を兼ねてもよい。   According to the lumen passage confirmation capsule 70 according to the seventh embodiment, the dissolution path 71 is divided by dividing the inside of the dissolution part 41 by the second and third non-dissolution parts 72 and 73 to form the dissolution path 71. Therefore, by lengthening the dissolution path 71, the time for the dissolution part 41 to dissolve in the lumen can be structurally lengthened, and thus the capsule shape can be maintained for a long time. Therefore, the capsule shape can be reliably maintained for a certain period of time necessary for confirming passage, and lumen passage can be confirmed with certainty. Further, the recognized portion may be a metal that does not transmit X-rays and is not dissolved in the intestine, or may be barium that can be dissolved in the intestine. Similarly to the fourth embodiment, the dissolving portion 41 and the non-dissolving portions 42, 72, and 73 may have radiopacity and may also serve as the recognized portion 15.

(実施の形態8)
本発明の実施の形態8に係る管腔通過確認カプセルについて図22および図23を参照して説明する。図22は、本実施の形態8に係る管腔通過確認カプセル80の構成例を示す中央部縦断側面図であり、図23は、正面図である。
(Embodiment 8)
A lumen passage confirmation capsule according to Embodiment 8 of the present invention will be described with reference to FIG. 22 and FIG. FIG. 22 is a vertical cross-sectional side view of the central portion showing a configuration example of the lumen passage confirmation capsule 80 according to the eighth embodiment, and FIG. 23 is a front view.

本実施の形態8に係る管腔通過確認カプセル80は、ドーム型カプセル形状の構造体をなす溶解部41の表面の数箇所、例えば4箇所に溶解部41が非溶解部42から表面に露出する開口部81を長手軸方向に線状に形成したものである。   In the lumen passage confirmation capsule 80 according to the eighth embodiment, the dissolution part 41 is exposed from the non-dissolution part 42 to the surface at several places, for example, four places on the surface of the dissolution part 41 forming the dome-shaped capsule-shaped structure. The opening 81 is formed linearly in the longitudinal axis direction.

このような構成の管腔通過確認カプセル80は、小腸内に滞留すると、図22(b)に示すように、溶解部41は表面に露出している開口部81部分から内部に向けて溶解が徐々に進行する。この間、表層の非溶解部42は、内部の溶解部41によってドーム型カプセル形状を維持している。その後、一定時間が経過して内部の大半の溶解部41が溶解すると、薄膜による非溶解部42は自身ではドーム型カプセル形状を維持できずばらばらに崩壊したり潰れたりすることとなり、狭窄部等であっても通過し得ることとなる。   When the lumen passage confirmation capsule 80 having such a configuration stays in the small intestine, as shown in FIG. 22 (b), the dissolving portion 41 is dissolved from the opening 81 portion exposed on the surface toward the inside. Progress gradually. During this time, the non-dissolving part 42 on the surface layer maintains a dome-shaped capsule shape by the dissolving part 41 inside. Thereafter, when most of the inner dissolution portion 41 is dissolved after a certain time has elapsed, the non-dissolution portion 42 made of a thin film cannot maintain the dome-shaped capsule shape by itself and breaks apart or is crushed. Even so, it can pass.

(変形例10)
図24は、変形例10の管腔通過確認カプセル80Aを示す中央部縦断側面図である。変形例10の管腔通過確認カプセル80Aは、非溶解部42の内周面側に内部の溶解部41を半径方向に分割して溶解部41中に表面の開口部81から内部に進行する溶解経路82を形成する第2の非溶解部83を放射状に設けたものである。すなわち、第2の非溶解部83は、開口部81→軸心部→非溶解部42の内面に向かうように半径方向に折り返される溶解経路82を形成している。
(Modification 10)
FIG. 24 is a vertical cross-sectional side view of the central portion showing the lumen passage confirmation capsule 80A of the modified example 10. In the lumen passage confirmation capsule 80A of the modified example 10, the inner dissolution part 41 is divided in the radial direction on the inner peripheral surface side of the non-dissolution part 42, and the dissolution progresses into the dissolution part 41 from the surface opening 81 to the inside. A second non-dissolving portion 83 that forms the path 82 is provided radially. That is, the second non-dissolving part 83 forms a dissolution path 82 that is folded back in the radial direction so as to go to the inner surface of the opening 81 → the axial center → the non-dissolving part 42.

このような構成の管腔通過確認カプセル80Aは、小腸内に滞留すると、図24(b)に示すように、開口部81によって外部に露出している溶解部41部分から溶解が始まり、第2の非溶解部83による溶解経路82に従い軸心部なる内部に向けて進行する。この間、表層の非溶解部42は、内部の溶解部41によってドーム型カプセル形状を維持している。その後、一定時間が経過して非溶解部42の内面部分の溶解部41まで溶解すると、薄膜による非溶解部42は自身ではドーム型カプセル形状を維持できずばらばらに崩壊したり潰れたりすることとなり、狭窄部等であっても通過し得ることとなる。   When the lumen passage confirmation capsule 80A having such a configuration stays in the small intestine, as shown in FIG. 24B, the dissolution starts from the dissolution portion 41 exposed to the outside through the opening 81, and the second It progresses toward the inside of the axial center according to the dissolution path 82 by the non-dissolving part 83. During this time, the non-dissolving part 42 on the surface layer maintains a dome-shaped capsule shape by the dissolving part 41 inside. After that, when a certain period of time elapses and the melting portion 41 of the inner surface portion of the non-dissolving portion 42 is melted, the non-dissolving portion 42 by the thin film itself cannot maintain the dome-shaped capsule shape and will be disintegrated or crushed apart. Even a narrowed portion or the like can pass through.

変形例10に係る管腔通過確認カプセル80Aによれば、溶解部41内を第2の非溶解部83によって分割して構造的に溶解時間が長くなる溶解経路82を形成しているので、溶解部41が管腔内で溶解する時間を構造的に長くすることができ、よって、カプセル形状を長時間維持することができる。よって、通過性を確認するために必要な一定時間、カプセル形状を確実に維持することができ、管腔通過性を確実に確認することができる。   According to the lumen passage confirmation capsule 80A according to the modified example 10, the inside of the dissolution part 41 is divided by the second non-dissolution part 83 to form the dissolution path 82 that has a structurally long dissolution time. The time for the portion 41 to dissolve in the lumen can be structurally increased, and thus the capsule shape can be maintained for a long time. Therefore, the capsule shape can be reliably maintained for a certain period of time necessary for confirming passage, and lumen passage can be confirmed with certainty.

なお、本実施の形態8や変形例10に係る管腔通過確認カプセル80,80Aの場合、溶解部41がドーム型カプセル形状の構造体をなすようにしたが、非溶解部42側をドーム型カプセル形状の構造体をなすように例えば柔軟性を有するように薄肉状に設けた場合であっても同様に適用することができる。このとき、非溶解部42は、溶解部41が溶解後、潰れることで小さくなる。   In the case of the lumen passage confirmation capsules 80, 80A according to the eighth embodiment and the tenth modification, the dissolving portion 41 is formed as a dome-shaped capsule-shaped structure. The present invention can be similarly applied even when it is provided in a thin shape so as to have, for example, flexibility so as to form a capsule-shaped structure. At this time, the non-dissolving part 42 becomes small by being crushed after the dissolving part 41 is dissolved.

本発明は、上述した実施の形態に限らず、本発明の趣旨を逸脱しない範囲であれば、種々の変形が可能である。例えば、上述の各実施の形態や各変形例では、管腔通過確認カプセルのカプセル形状として、長手軸方向の両端にドーム状の凸形状部11a,11bを有するドーム型カプセル形状の例で説明したが、適用対象となるカプセル型内視鏡の短手軸方向の直径程度の大きさの球型カプセル形状であっても適用可能である。また、非溶解部として基本的に体内で溶解しない材料により形成した例で説明したが、溶解部との関係において相対的に体内で溶解しない材料であればよく、体内で溶解する材料であっても溶解部を構成する材料に比して溶解する時間が長いもの(溶解しにくいもの)であれば適用可能である。   The present invention is not limited to the above-described embodiment, and various modifications can be made without departing from the spirit of the present invention. For example, in the above-described embodiments and modifications, the capsule shape of the lumen passage confirmation capsule has been described as an example of a dome-shaped capsule shape having dome-shaped convex portions 11a and 11b at both ends in the longitudinal axis direction. However, the present invention can also be applied to a spherical capsule shape having a diameter approximately equal to the diameter in the short axis direction of the capsule endoscope to be applied. In addition, although the example in which the non-dissolving part is basically formed of a material that does not dissolve in the body has been described, any material that does not dissolve relatively in the body in relation to the dissolving part may be used. In addition, any material can be used as long as the material dissolves in a longer time than the material constituting the melted part (is difficult to dissolve).

本発明の実施の形態1に係る管腔通過確認カプセルの構成例を示す概略斜視図である。It is a schematic perspective view which shows the structural example of the lumen passage confirmation capsule which concerns on Embodiment 1 of this invention. 図1の中央縦断側面図である。It is a center longitudinal cross-sectional side view of FIG. 変形例1の管腔通過確認カプセルを示す概略縦断側面図である。It is a schematic longitudinal cross-sectional side view which shows the lumen passage confirmation capsule of the modification 1. 変形例2の管腔通過確認カプセルを示す概略斜視図である。10 is a schematic perspective view showing a lumen passage confirmation capsule of a second modification. FIG. 変形例3の管腔通過確認カプセルを示す概略斜視図である。FIG. 10 is a schematic perspective view showing a lumen passage confirmation capsule of a third modification. 図5の端面側面図である。It is an end surface side view of FIG. 本発明の実施の形態2に係る管腔通過確認カプセルの構成例を示す概略斜視図である。It is a schematic perspective view which shows the structural example of the lumen passage confirmation capsule which concerns on Embodiment 2 of this invention. 図7の中央縦断側面図である。It is a center longitudinal cross-sectional side view of FIG. 変形例4の管腔通過確認カプセルを示す概略斜視図である。It is a schematic perspective view which shows the lumen passage confirmation capsule of the modification 4. 変形例5の管腔通過確認カプセルを示す中央縦断側面図である。It is a center longitudinal cross-sectional side view which shows the lumen passage confirmation capsule of the modification 5. FIG. 分断された非溶解部の変形の様子を示す断面図である。It is sectional drawing which shows the mode of a deformation | transformation of the non-dissolved part parted. 変形例6の管腔通過確認カプセルを示す中央縦断側面図である。It is a center longitudinal cross-sectional side view which shows the lumen passage confirmation capsule of the modification 6. FIG. 本発明の実施の形態3に係る管腔通過確認カプセルの構成例を示す中央縦断正面図である。It is a center longitudinal cross-section front view which shows the structural example of the lumen passage confirmation capsule which concerns on Embodiment 3 of this invention. 変形例7の管腔通過確認カプセルを示す部分断面図である。FIG. 10 is a partial cross-sectional view showing a lumen passage confirmation capsule of a modification 7. 本発明の実施の形態4に係る管腔通過確認カプセルを示す縦断正面図である。It is a vertical front view which shows the lumen passage confirmation capsule which concerns on Embodiment 4 of this invention. 変形例8の管腔通過確認カプセルを示す縦断正面図である。It is a vertical front view which shows the lumen passage confirmation capsule of the modification 8. 本発明の実施の形態5に係る管腔通過確認カプセルの構成例を示す縦断正面図である。It is a vertical front view which shows the structural example of the lumen passage confirmation capsule which concerns on Embodiment 5 of this invention. 図17の側面図である。It is a side view of FIG. 本発明の実施の形態6に係る管腔通過確認カプセルの構成例を示す縦断正面図である。It is a vertical front view which shows the structural example of the lumen passage confirmation capsule which concerns on Embodiment 6 of this invention. 変形例9の管腔通過確認カプセルを示す縦断正面図である。It is a vertical front view which shows the lumen passage confirmation capsule of the modification 9. 本発明の実施の形態7に係る管腔通過確認カプセルの構成例を示す縦断正面図である。It is a vertical front view which shows the structural example of the lumen passage confirmation capsule which concerns on Embodiment 7 of this invention. 本発明の実施の形態8に係る管腔通過確認カプセルの構成例を示す中央部縦断側面図である。It is a center part vertical side view which shows the structural example of the lumen passage confirmation capsule which concerns on Embodiment 8 of this invention. 図22の正面図である。FIG. 23 is a front view of FIG. 22. 変形例10の管腔通過確認カプセルを示す中央部縦断側面図である。It is a center part vertical side view which shows the lumen passage confirmation capsule of the modification 10. FIG.

符号の説明Explanation of symbols

11a,11b 凸形状部
12 非溶解部
13 溶解部
14 溶解部
15,15a,15b 被認識部
16 非溶解部
17 溶解経路
18 非溶解部
41 溶解部
42 非溶解部
42a 端部
43 開口部
61 開口部
62 溶解経路
63 非溶解部
63a 端部
64 非溶解部
81 開口部
82 溶解経路
83 非溶解部
11a, 11b Convex-shaped portion 12 Non-dissolving portion 13 Dissolving portion 14 Dissolving portion 15, 15a, 15b Recognized portion 16 Non-dissolving portion 17 Dissolution path 18 Non-dissolving portion 41 Dissolving portion 42 Non-dissolving portion 42a End portion 43 Opening portion 61 Opening Part 62 Dissolution path 63 Non-dissolution part 63a End part 64 Non-dissolution part 81 Opening part 82 Dissolution path 83 Non-dissolution part

Claims (19)

体内に導入可能な大きさのカプセル形状を有する管腔通過確認装置であって、
体内で溶解しない材料からなり、前記カプセル形状の表面の一部を除いて薄肉状に設けられた第1の非溶解部と、
体内で溶解する材料からなり、外部に露出する前記カプセル形状の表面の一部を含み前記第1の非溶解部の内部に設けられた溶解部と、
体内で溶解しない材料からなり、前記溶解部内を分割して該溶解部中に表面の前記一部から内部に進行する溶解経路を形成する第2の非溶解部と、
を備えることを特徴とする管腔通過確認装置。
A lumen passage confirmation device having a capsule shape that can be introduced into the body,
A first non-dissolving portion made of a material that does not dissolve in the body and provided in a thin shape excluding a part of the capsule-shaped surface;
A dissolving portion made of a material that dissolves in the body, including a part of the capsule-shaped surface exposed to the outside, and provided inside the first non-dissolving portion;
A second non-dissolving part that is made of a material that does not dissolve in the body, divides the inside of the dissolving part, and forms a dissolution path that proceeds from the part of the surface to the inside in the dissolving part;
A lumen passage confirmation device comprising:
前記第2の非溶解部は、カプセル形状の中心方向に伸展するように設けられていることを特徴とする請求項1に記載の管腔通過確認装置。   The lumen passage confirmation device according to claim 1, wherein the second non-dissolving part is provided so as to extend in a center direction of the capsule shape. 体内で溶解しない材料からなり、前記溶解経路をさらに分割して細分化する第3の非溶解部を備えることを特徴とする請求項2に記載の管腔通過確認装置。   The luminal passage confirmation device according to claim 2, further comprising a third non-dissolving portion made of a material that does not dissolve in the body and further dividing and subdividing the dissolution path. 前記第2の非溶解部の端部は、カプセル形状の表面において第1の非溶解部の端部に繋がっていることを特徴とする請求項2または3に記載の管腔通過確認装置。   4. The lumen passage confirmation device according to claim 2, wherein an end portion of the second non-dissolving portion is connected to an end portion of the first non-dissolving portion on a capsule-shaped surface. 前記第2の非溶解部は、前記第1の非溶解部に対して略平行で層状に設けられていることを特徴とする請求項1に記載の管腔通過確認装置。   2. The lumen passage confirmation device according to claim 1, wherein the second non-dissolving part is provided in a layer shape substantially parallel to the first non-dissolving part. 被認識部材を有することを特徴とする請求項1〜5のいずれか一つに記載の管腔通過確認装置。   6. The lumen passage confirmation device according to claim 1, further comprising a member to be recognized. 前記被認識部材は、X線不透過材であることを特徴とする請求項6に記載の管腔通過確認装置。   The lumen recognition device according to claim 6, wherein the member to be recognized is a radiopaque material. 前記X線不透過材は、前記非溶解部の少なくとも一部に設けられていることを特徴とする請求項7に記載の管腔通過確認装置。   The lumen passage confirmation device according to claim 7, wherein the radiopaque material is provided in at least a part of the non-dissolving part. 前記非溶解部は、金属膜からなることを特徴とする請求項1〜8のいずれか一つに記載の管腔通過確認装置。   9. The lumen passage confirmation device according to claim 1, wherein the non-dissolving part is made of a metal film. 前記X線不透過材は、前記溶解部に内蔵されていることを特徴とする請求項7に記載の管腔通過確認装置。   The luminal passage confirmation device according to claim 7, wherein the radiopaque material is built in the dissolution part. 前記X線不透過材は、前記溶解経路の最奥部に配置されていることを特徴とする請求項10に記載の管腔通過確認装置。   The lumen passage confirmation device according to claim 10, wherein the radiopaque material is disposed in the innermost part of the dissolution path. 前記X線不透過材は、複数個所に離間配置されていることを特徴とする請求項10または11に記載の管腔通過確認装置。   12. The lumen passage confirmation device according to claim 10 or 11, wherein the radiopaque material is spaced apart at a plurality of locations. 前記被認識部材は、前記溶解部に内蔵されたRF−IDタグであることを特徴とする請求項6に記載の管腔通過確認装置。   The lumen recognition device according to claim 6, wherein the member to be recognized is an RF-ID tag built in the dissolving portion. 前記溶解部の少なくとも一部は、腸溶性材料からなることを特徴とする請求項1〜13のいずれか一つに記載の管腔通過確認装置。   The lumen passage confirmation device according to claim 1, wherein at least a part of the dissolving portion is made of an enteric material. 前記カプセル形状は、長手軸方向の両端に凸形状部を有するドーム型カプセル形状であることを特徴とする請求項1〜14のいずれか一つに記載の管腔通過確認装置。   The lumen passage confirmation device according to any one of claims 1 to 14, wherein the capsule shape is a dome-shaped capsule shape having convex portions at both ends in the longitudinal axis direction. 前記カプセル形状は、球型カプセル形状であることを特徴とする請求項1〜14のいずれか一つに記載の管腔通過確認装置。   The lumen passage confirmation device according to any one of claims 1 to 14, wherein the capsule shape is a spherical capsule shape. 体内で溶解しない材料からなる前記非溶解部は、体内で溶解する時間が前記溶解部よりも長いことにより相対的に体内で溶解しない特性を示すことを特徴とする請求項1〜16のいずれか一つに記載の管腔通過確認装置。   17. The non-dissolving part made of a material that does not dissolve in the body exhibits a characteristic that the non-dissolving part is relatively insoluble in the body by being longer in the body than the dissolving part. The lumen passage confirmation device according to one. 前記溶解部は、X線不透過部材からなり、前記被認識部を兼ねることを特徴とする請求項7に記載の管腔通過確認装置。   8. The lumen passage confirmation device according to claim 7, wherein the dissolving portion is made of an X-ray opaque member and also serves as the recognized portion. 前記被認識部は、バリウムまたは金属を含むことを特徴とする請求項7,8,10,11,12,18のいずれか一つに記載の管腔通過確認装置。   The lumen recognition device according to any one of claims 7, 8, 10, 11, 12, and 18, wherein the recognized portion includes barium or metal.
JP2007019911A 2007-01-30 2007-01-30 Lumen passage confirmation device Expired - Fee Related JP4839236B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2007019911A JP4839236B2 (en) 2007-01-30 2007-01-30 Lumen passage confirmation device
EP08703541.6A EP2106732B1 (en) 2007-01-30 2008-01-21 Device for checking for lumen passage and method of producing device for checking for lumen passage
PCT/JP2008/050691 WO2008093554A1 (en) 2007-01-30 2008-01-21 Device for checking for lumen passage and method of producing device for checking for lumen passage
CN200880003574.7A CN101600384B (en) 2007-01-30 2008-01-21 Device for checking for lumen passage
US12/512,386 US20090292173A1 (en) 2007-01-30 2009-07-30 Lumen passability checking device and method of manufacturing lumen passability checking device

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007019911A JP4839236B2 (en) 2007-01-30 2007-01-30 Lumen passage confirmation device

Publications (2)

Publication Number Publication Date
JP2008183239A true JP2008183239A (en) 2008-08-14
JP4839236B2 JP4839236B2 (en) 2011-12-21

Family

ID=39726663

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007019911A Expired - Fee Related JP4839236B2 (en) 2007-01-30 2007-01-30 Lumen passage confirmation device

Country Status (1)

Country Link
JP (1) JP4839236B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8523788B2 (en) 2002-07-11 2013-09-03 Given Imaging Ltd. Device, system and method for examining a body lumen
DE102010034470B4 (en) 2009-08-06 2021-07-15 Given Imaging Ltd. Apparatus, system and method for examining a body lumen

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004248956A (en) * 2003-02-21 2004-09-09 Fuji Photo Optical Co Ltd Pretest capsule for endoscope
JP2005508668A (en) * 2001-07-12 2005-04-07 ギブン・イメージング・リミテッド Apparatus and method for examining a body lumen
JP2006142013A (en) * 2004-11-12 2006-06-08 Given Imaging Ltd Device and method for examining body lumen

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005508668A (en) * 2001-07-12 2005-04-07 ギブン・イメージング・リミテッド Apparatus and method for examining a body lumen
JP2004248956A (en) * 2003-02-21 2004-09-09 Fuji Photo Optical Co Ltd Pretest capsule for endoscope
JP2006142013A (en) * 2004-11-12 2006-06-08 Given Imaging Ltd Device and method for examining body lumen

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8523788B2 (en) 2002-07-11 2013-09-03 Given Imaging Ltd. Device, system and method for examining a body lumen
DE102010034470B4 (en) 2009-08-06 2021-07-15 Given Imaging Ltd. Apparatus, system and method for examining a body lumen

Also Published As

Publication number Publication date
JP4839236B2 (en) 2011-12-21

Similar Documents

Publication Publication Date Title
AU2002317466B2 (en) Device and method for examining a body lumen
EP1685797B1 (en) Device and method for examining a body lumen
EP2702964A1 (en) Stent
CN110191667B (en) Device and method for enhancing the visual effects of the small intestine
JP5060721B2 (en) Device for examining body cavities
AU2002317466A1 (en) Device and method for examining a body lumen
US11684315B2 (en) Gastric resident electronics
JP2004248956A (en) Pretest capsule for endoscope
JP4891795B2 (en) Lumen passage confirmation device and method for manufacturing lumen passage confirmation device
JP2006142013A6 (en) Apparatus and method for examining body lumen
JP4839236B2 (en) Lumen passage confirmation device
JP4939242B2 (en) Lumen passage confirmation device
US10675248B2 (en) Expandable pill
EP2110066A1 (en) Device for checking for lumen passage and method of checking for lumen passage
EP2111788B1 (en) Device for checking for lumen passage
US8523788B2 (en) Device, system and method for examining a body lumen
JP5086653B2 (en) Lumen passage confirmation device
JP6006456B1 (en) Lumen passage confirmation device
EP2106732B1 (en) Device for checking for lumen passage and method of producing device for checking for lumen passage
JP2008183240A5 (en)
JP2019058332A (en) Balloon catheter

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20091130

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110920

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111003

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141007

Year of fee payment: 3

R151 Written notification of patent or utility model registration

Ref document number: 4839236

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141007

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees